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FDA REGULATION OF ELECTRONIC
NICOTINE DELIVERY SYSTEMS AND
THE “DEEMING” RULE: WHAT’S
LEFT FOR STATES?
WILLIAM TILBURG, KATHLEEN HOKE, & MELLISSA SAGER
Beginning August 8, 2016, electronic nicotine delivery systems
(“ENDS”), commonly referred to as electronic cigarettes or ecigarettes, are subject to the authority of the U.S. Food and Drug
Administration (“FDA”) and regulated as tobacco products under
federal law. Laws prohibiting sales to minors, requiring ID checks,
restricting vending machine purchases, and mandating health
warning labels that currently apply to cigarettes, smokeless tobacco,
and other “conventional tobacco products” will extend to ENDS. The
new regulations do not have preemptive effect, meaning state and
local governments retain authority to enact additional restrictions on
the distribution, sale, and use of ENDS. At the same time, the
European Union has embraced ENDS as a safer alternative to
smoking conventional tobacco products, with laws reflecting that
policy position.
The new regulations provoke the question of whether these devices,
which aerosolize a liquid nicotine solution that is inhaled in a manner
similar to conventional smoking, should be subject to the same
restrictions as conventional tobacco products? ENDS aerosol
contains toxicants, including known human carcinogens, but at
significantly lower levels than found in conventional tobacco
products. And, while the long term health effects associated with
ENDS are unknown, they are almost certainly less harmful than
conventional tobacco products. Experimental and observational
studies also suggest ENDS may be effective smoking cessation tools.
On the other hand, ENDS use among high school students increased
tenfold from 2011 to 2015 (4.5% to 44.9%) and a growing body of
evidence indicates youth ENDS users are significantly more likely to
initiate use of conventional tobacco products.
In light of rising youth use, uncertainty surrounding the long term
health effects, and potential for helping adult smokers quit, how
should state and local governments regulate these devices? This
article
will
summarize
the
new
federal regulations governing ENDS, review scientific studies on the
health effects and potential cessation benefits associated with ENDS,
and discuss policy options to reduce youth access and use that do not
27
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prevent or unduly burden adult smokers from using ENDS to quit
smoking.
I. INTRODUCTION
Smoking has been the leading cause of preventable death in the United
States for many decades.1 This list of diseases and other negative health
consequences caused by smoking is extensive; exposure to secondhand smoke
creates similar health outcomes.2 As a result, medical and public health
professionals are naturally concerned about the marketing of any product that
emulates smoking yet are eager to offer smokers truly effective tools for
cessation.3 This is why the electronic cigarette creates a conundrum for those
working to reduce smoking and improve public health. Is this new product as
bad as its namesake? Or is it a safe, viable method to achieve cessation?
As researchers embarked on the time-consuming and expensive process of
determining the health effects and cessation potential of electronic cigarettes—
now better terms electronic nicotine delivery systems or ENDS—the product
exploded in the marketplace. No longer a quirky, expensive mystery device sold
at mall kiosks, ENDS are becoming ubiquitous, available in cheap disposable
versions and elaborate, pricey, reusable devices with high-tech options. The
liquid nicotine market has likewise developed rapidly to offer consumers
virtually any flavor imaginable and a variety of nicotine levels.4 Specialty vape
shops now pepper communities. ENDS are advertised in the same media venues
as cigarettes—magazines and point-of-sale—and where cigarette promotion is
forbidden—television and radio. Celebrities have touted the benefits of ENDS
on network television and been seen using the product at major entertainment
events.5 ENDS are used indoors in places where smoking has long been
© 2017 William Tillburg, Kathleen Hoke & Mellissa Sager.
1. OFFICE OF THE SURGEON GEN’L, U.S. DEPT OF HEALTH AND HUMAN SERV., THE HEALTH
CONSEQUENCES OF SMOKING –50 YEARS OF PROGRESS, A REPORT OF THE SURGEON GENERAL,
EXECUTIVE SUMMARY at iii (2014) (hereinafter “Surgeon General’s Report”), available at
http://www.surgeongeneral.gov/library/reports/50-years-of-progress/exec-summary.pdf.
2. See id. (explaining that active smoking is causally associated with numerous cancer related
illnesses and other illnesses, and secondhand smoking is causally associated with increased risk of stroke).
3. See Carrie Arnold, Vaping and Health: What Do We Know about E-Cigarettes?, 122 ENVTL.
HEALTH PERSPECTIVES A244, A245–46 (2014), (reporting that, while health professionals believe ecigarettes are not harmless, e-cigarettes may be a preferred alternative to smoking).
4. Joseph G. Allenet. al., Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and
Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes,
ENVTL. HEALTH PERSPECTIVES, at 3 (Dec. 8, 2015), http://ehp.niehs.nih.gov/wpcontent/uploads/advpub/2015/12/ehp.1510185.acco.pdf (finding that over 7000 flavors of e-cigarettes are
currently marketed); see Caroline Chen et al., E-Cigarette Design Preference and Smoking Cessation: A
U.S. Population Study, AM. J. PREVENTATIVE MED. 356, 360 (2016) (explaining that users can choose
higher strengths of nicotine and many different e-liquid flavors).
5. See also Brittney Stephens, 6 Times Leonardo DiCaprio Has Hit the Vape During a Big Event,
POPSUGAR (Feb. 12, 2016), http://www.popsugar.com/celebrity/Leonardo-DiCaprio-Smoking-VapingEvents-40023817#photo-40023817 (describing the overwhelming social media response to an award-
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prohibited. Vaping consumers ardently supports ENDS, both as cessation
devices and as a product offering the same enjoyment as cigarettes with much
reduced risk or negative health outcomes. Within this frenzy, research moves
forward
as
best
possible.
Little is known about the long-term health effects and public health impact
of ENDS. Preliminary research raises concerns, particularly to a public health
community still waging a decades-long battle against the original cigarette.
Policymakers and public health officials are stymied, having to take action and
engage in public education with a modest amount of research. Caution has
prevailed to some extent at the federal level; the FDA promulgated a regulation
deeming ENDS tobacco products subject to the Family Smoking Prevention and
Tobacco Control Act (“Tobacco Control Act”) and the agency’s regulatory
power.6 Effective August 8, 2016, the FDA regulations impose requirements
and restrictions on ENDS, some relatively minor and others far more significant.7
The impact of the regulation cannot yet be measured and we fully anticipate that
FDA will issue additional provisions and guidance related to ENDS.
Researchers will have to wait to determine the full impact of the federal
regulation of ENDS. In the meantime, federal law gives wide room for state and
local
jurisdictions
to
do
more.
Section II of this paper provides a brief history into ENDS. In Section III,
we set out information about the marketing history, including data on sales, and
in Section IV we explore the demographics of ENDS users. Section V discusses
the available research, summarizing what is known and noting the need for
additional research to support policymakers and public health professionals,
Section VI includes the history of federal regulation of tobacco, which leads into
Section VII, which explains the new FDA regulation of ENDS via the so-called
deeming rule. Finally, Section VIII suggests policy options for state and local
governments interested in expanding upon the regulatory scheme established by
FDA.

winning actor openly using a vape pen during a televised award show, among others); Cf. John Tozzi,
Celebrities Pitching E-Cigarettes Make a Nightmare for Public Health Officials, BLOOMBERG BUS.WK.
(June 30, 2014, 4:34 PM),https://www.bloomberg.com/news/articles/2014-06-30/celebrities-pitching-ecigarettes-make-a-nightmare-for-public-health-officials (describing that through use of celebrities in
marketing, e-cigarette brands are eroding the stigma of smoking that had been established in part by
advertising bans); see, e.g., CANADAVAPES, Katherine Heigl & David Letterman Vape Electronic
Cigarettes, YOUTUBE (Sept. 29, 2010), https://www.youtube.com/watch?v=ysGyfLwwr1s (presenting a
clip from a network television show where two celebrities discuss e-cigarettes as a tool to quit smoking);
6. 21 C.F.R. §§ 1100, 1140, 1143 (2016).
7. See 21 C.F.R. § 1100, 1140, 1143 (2016) (stating that the rule extends the FDA’s authority to all
statutorily defined “tobacco products,” prohibits the sale of such products to minors, and requires warning
labels on the covered products).
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II. HISTORY OF THE DEVICES
Defining and describing an electronic nicotine delivery system (ENDS) is
not an easy task as the product category has changed significantly over time and
continues to be diverse and anything but static in design and features.8 The
changing nature of the product is exacerbated by users modifying the product in
various ways; there are videos available on the Internet that offer advice on how
to modify an ENDS for a more potent or pleasant user experience.9 Similarly,
the marketing of ENDS, such as where they are sold, how much they cost and
how they are advertised, has been dynamic over the decade or so since the
product has been on the market in the U.S.10 We use the term ENDS in this piece
to capture the array of products that allow a user to inhale aerosolized liquid,
typically containing nicotine, through an electronic device but researchers,
manufacturers and consumers use a variety of terms to refer to ENDS. A brief
history of ENDS in the U.S. helps to define the landscape on which regulation
of
the
product
will
proceed.
The first version—or generation—was the closed-system electronic
cigarette, often referred to as the cig-alike.11 Although far less popular now than
later versions, cig-alike ENDS remain on the market today.12 These firstgeneration devices are cylinder-shaped like cigarettes13 and are about the same
size, just slightly longer and larger in diameter.14 The cig-alike body can be

8. See generally U.S. E-Cigarette Regulation: A 50 State Review, PUB. HEALTH L. CTR. (2016),
available at http://www.publichealthlawcenter.org/sites/default/files/E-Cigarette-Legal-Landscape-50State-Review-November-2016.pdf (showing the various attempts of state legislatures to define and
regulate e-cigarettes); see also History of Electronic Cigarettes, QUITDAY, https://quitday.org/electroniccigarettes/history-of-electronic-cigarettes/ (last visited Nov. 3, 2016) (discussing the rapid development
of features and technologies following a surge in popularity of e-cigarettes).
9. See also Caleb Kekahbah, E-Cig simplified.com – E-Cigarette Cartridge Modification,
YOUTUBE (Oct. 13, 2010), https://www.youtube.com/watch?v=6_3Gbkz4150 (demonstrating homemade
methods of modifying e-cigarettes).See MASHABLE, How to Hack Your Own E-Cigarettes, YOUTUBE
(Jan. 24, 2014), https://www.youtube.com/watch?v=rmxwnuTRMiw (describing various methods of ecigarette modification).https://www.youtube.com/watch?v=6_3Gbkz4150 (demonstrating homemade
methods of modifying e-cigarettes).
10. See Arnold, supra note 3, at A246–47 (discussing market changes including the shift in sales
from a largely online market to more “brick-and-mortar stores”).
11. See Lynne Dawkins, Cigalike vs. Refillable E-Cigarettes: Don’t Stub Out the Cigalikes Just
Yet…, SAVEE-CIGS.COM (Aug. 10, 2014), https://saveecigs.wordpress.com/2014/08/10/cigalike-vsrefillable-e-cigarettes-dont-stub-out-the-cigalikes-just-yet/ (discussing the difference between a nonrefillable, closed system e-cigarette and later refillable types of e-cigarettes).
12. See Tripp Mickle, E-Cigarette Sales Rapidly Lose Steam, WALL ST. J. (Nov. 17, 2015),
http://www.wsj.com/articles/e-cig-sales-rapidly-lose-steam-1447798921 (citing a “slowdown”, a 21%
drop in sales, of cig-alike models of e-cigarettes).
13. See Volt – Pro Starter Kit, SMOKELESSIMAGE, Image 4, http://smokelessimage.com/starterkits/voltpro.html (last visited Feb. 3, 2017); see also Dawkins, supra note 11.
14. See Konstantinos Farsalinos et al., Nicotine Absorption from Electronic Cigarette Use:
Comparison Between First and New-Generation Devices, 4 SCI. REP. 1, 1 (2014) (explaining that these
small devices are similar to regular tobacco cigarettes); Jessica M. Yingst et al., Factors Associated with
Electronic Cigarette Users’ Device Preferences and Transition From First Generation to Advanced
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constructed of metal or heavy plastic.15 Coloration varies from those designed
to look like a cigarette with a brown “filter” at one end and a longer section of
white making up the shaft to those with an all-black design.16 Although the cigalike does not actually burn, most of the products have a lighted end that glows
as the user draws on the cig-alike.17 The coloration of the lighted end also varies,
with some cig-alikes having a red/orange light, some a grey color and one
popular product with a blue light.18 The first-generation electronic cigarette is
comprised of three parts: an enclosed battery, a reservoir for liquid, and a heating
element.19 The heating element uses power from the battery to change the liquid
into an aerosol, often referred to as vapor.20 The liquid reservoir in a cig-alike is
a prefilled cartridge.21 Some cartridges are inaccessible to the user, making the
device disposable as the device has no purpose once the enclosed liquid is
depleted through use.22 The batteries in these cig-alikes are not rechargeable.
The design of other cig-alikes differs in that the cartridge can be removed and
replaced with another closed cartridge; these cig-alikes have a rechargeable
battery, typically using a USB port for charging.23 The voltage in the nonrechargeable or the rechargeable battery in a cig-alike is fixed, not subject to
consumer alteration.24 For non-disposable cig-alikes, the replacement cartridges

Generation Devices, 17 NICOTINE & TOBACCO RES. 1242, 1243 (2015) (noting that the devices shaped
like a cigarette are also classified as “cigalikes”).
15. Konstantinos Farsalinos et al., Are Metals Emitted from Electronic Cigarettes a Reason for
Health Concern? A Risk–Assessment Analysis of Currently Available Literature, 12 INT’L. J. ENVTL. RES.
& PUB. HEALTH 5215, 5216 (2015).
16. Rachel Grana et al., Background Paper on E-Cigarettes, WHO TOBACCO CONTROL PAPERS 1,
13–14 (2013), http://escholarship.org/uc/item/13p2b72n.
17. Hayden
McRobbie,
Electronic
Cigarettes,
NCSCT
(2014),
at
4,
http://www.ncsct.co.uk/usr/pub/e-cigarette_briefing.pdf.
18. What Is a Cigalike?, VAPERANKS, http://vaperanks.com/what-is-a-cigalike/ (last visited Feb. 20,
2017) (explaining that some cigalikes have LED tips that light up red because are designed to look like
real tobacco cigarettes); Lindsay Fox, Njoy Electronic Cigarette Review, ECIGARETTE REVIEWED (Apr. 8,
2016), http://ecigarettereviewed.com/njoy-electronic-cigarette-review (reviewing an electronic cigarette
that has a grey plastic tip with an LED that lights up white as the user inhales); How Blu Disposables
Work, BLU, https://www.blu.com/en/US/explore/about-blu-products/disposable-e-cigarettes.html (last
visited Feb. 20, 2017) (explaining that when the user inhales, the blue LED tip with light up).
19. McRobbie, supra note 17.
20. Tianrong Cheng, Chemical evaluation of Electronic Cigarettes, 23 TOBACCO CONTROL ii11, ii11
(2014).
21. Chen et al., supra note 4, at 356.
22. Id.
23. See id. at 360 (explaining that closed system cig-alikes can be reloaded with cartridges filled by
the manufacturers); see also 4 Ways You Can Keep Your E-Cigarette Battery Charged and Working For
You, EVERSMOKE ELECTRONIC CIGARETTES, http://www.learn.eversmoke.com/keep-your-e-cig-batterycharged.html (last visited Feb. 20, 2017) (explaining that batteries do not last indefinitely, and can
typically be plugged into a laptop or other device with a USB port).
24. E-Cigarette Use Among Youth Adults: A Report of the Surgeon General, U.S. DEP’T OF HEALTH
&
HUM.
SERV.
151
(2016),
available
at
https://ecigarettes.surgeongeneral.gov/documents/2016_SGR_Full_Report_non-508.pdf; see also R.J. Reynolds
Vapor Company, VUSE: Digital vapor cigarettes, Frequently Asked Product Related Questions, VUSE,
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are not designed to be filled by the consumer; rather, they are supposed to be
discarded and replaced with a new, pre-filled cartridge.25 For this reason, cigalikes, whether disposable or reusable, are referred to as closed-system ENDS.26
Of course, some clever consumers found that they could save money by refilling
the cartridges from vials of e-liquid.27 This is an adulteration of the firstgeneration
ENDS
that
foreshadowed
the
future
generations.
Later generations of ENDS developed rapidly, with product changes
reflecting increases in technology and enhanced flexibility for consumers to
exercise more control over the device. Although the diversity in products makes
it difficult to define any one product variety, there are common characteristics of
the more modern ENDS devices.28 In contrast to cig-alikes, most of the later
generation ENDS products are open systems, meaning the product has a
refillable reservoir or tank into which e-liquid is poured.29 Open-system ENDS
entered the market as e-pens and similar products.30 This iteration of the ENDS
does not look quite like a cigarette; rather, the product may look like a large pen
or even a lipstick case.31 These are generally cylindrical and modest in size.32
Often these are worn on lanyard around the user’s neck.33 As with any consumer
good, however, consumer demand and technology advances changed this
product line quickly.34 The more modern open-system ENDS boast a much
larger e-liquid tank than early models; this is a factor of convenience as the
https://www.vusevapor.com/FooterLinks/ProductFAQs (last visited Feb. 20, 2017) (“VUSE intentionally
does not offer refillable replacement Cartridges to help ensure that our products cannot be modified and
in turn, offer only a superior vaping experience…. The Lithium Polymer battery is housed inside the
VUSE PowerUnit and is not accessible.”).
25. Id.
26. Chen et al., supra note 4, at 356.
27. smokevapure, How To Fill An E-Cigarette Cartridge With E-Liquid, YOUTUBE (Sept. 28, 2010),
https://www.youtube.com/watch?v=cr4yPtYvzO0.
28. See Conference of the Parties to the WHO Framework Convention on Tobacco Control,
Electronic Nicotine Delivery Systems and Electronic Non-Nicotine Delivery Systems (ENDS/ENNDS), ¶
3, FCTC/COP/7/11(Aug. 2016) (“All ENDS/ENNDS heat a solution (e-liquid) to create an aerosol which
frequently contains flavourants, usually dissolved into Propylene Glycol or/and Glycerin.”).
29. See Nancy Kaufman & Margaret Mahoney, E-Cigarettes: Policy Options and Legal Issues
Amidst Uncertainty, 43 J. L. MED. & ETHICS (SPEC. SUPP. TO VOL. 43.1) 23, 23 (2015).
30. See id. (noting that open-system ENDS rapidly entered the market in various designs including
e-pens, vape pens, and other customizable devices).
31. See Regulating Electronic Cigarettes and Similar Devices, TOBACCO CONTROL LEGAL
CONSORTIUM 1, 2 (2014) (describing modern ENDS which come in a “variety of shapes mimicking
common household products, such as flash drives, pens, and lipstick.”); see also Grana et al., supra note
16, at 14, fig.2. (depicting an example of a pen-style ENDS).
32. See Regulating Electronic Cigarettes and Similar Devices, supra note 31 (stating that pen-style
ENDS are shaped like cigarettes but slightly larger).
33. See Matt Richtel, Where Vapor Comes Sweeping Down the Plain: E-Cigarettes Take Hold in
Oklahoma, N.Y. TIMES (Apr. 26, 2014), https://www.nytimes.com/2014/04/27/business/e-cigarettestake-hold-in-oklahoma.html?_r=0 (describing an e-cigarette user who wears his e-cigarette on a lanyard
around his neck).
34. See Grana et al., supra note 16, at 12 (“Product engineering has been evolving since the first ecigarettes were documented as arriving on the global market in 2007.”).
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consumer is not required to refill the tank as frequently as with the first opensystem models or as often as the cartridges would be replaced in a rechargeable
cig-alike.35 Many of these modern models allow the consumer to adjust the
voltage of the heating element, either through changing the battery or making an
adjustment on the device itself.36 These are often referred to as variable voltage
devices; the voltage delivered ranges from 3.0V to 7.0V.37 Adjustments to the
voltage impact the heating temperature which in turn impacts the quality and
quantity of aerosol inhaled by the consumer and may impact the actual nicotine
delivery.38 High-tech versions of this line of ENDS could have pumps connected
to micromechanical systems, allowing consumers more control over delivery of
the aerosol.39 Advanced ENDS may also contain “programmable logic units,
integrated circuits, and other electronic components that are used to display
average use cycle and safety warnings.”40 These available variations result in
more than 466 brands of ENDS on the market as of 2014.41 Although
technological advances coupled with anticipated product regulation may
ultimately result in consistency, testing of existing ENDs products reveals that
“[q]uality of product functioning and performance is highly variable and
inconsistent.”42
Changes and diversity in the ENDS product lines are likewise mirrored in
the e-liquid market. Initially, with closed systems, e-liquid was available in the
sealed cartridges and in a few flavors.43 As the open system product lines

35. See id. at 13, 14 fig.2 (showing Figure 2 to illustrate a large, tank-style ENDS after noting that
larger tank systems “hold several ml of e-liquid” requiring fewer refills).
36. See McRobbie, supra note 17, at 6 (explaining that users can adjust the voltage of the device by
changing the settings directly on the device or replacing the coils and wicks in the device); see also Aaron
Bonner, Head in the Clouds: Vaping Culture Continues in Tuscaloosa, THE CRIMSON WHITE (Sept. 8,
2016, 7:46 AM), http://www.cw.ua.edu/article/2016/09/tuscaloosa-vape-culture (“Those interested in
modifying their kit can upgrade coils and batteries to increase voltage and intake…”).
37. Brown & Cheng, Electronic Cigarettes: Product Characterisation and Design Considerations,
23 TOBACCO CONTROL (SUPPLEMENTAL ISSUE 2), at ii7 (May 2014) (giving an example of a variable
voltage range of “3-6 V in 0.1 V increments[.]”).
38. See Grana et al., supra note 16, at 12 (“Battery voltage differences and unit circuitry can result in
great variability in the products’ ability to heat and convert the nicotine solution to an aerosol and,
consequently, may affect actual nicotine delivery and other chemicals delivered to users and emitted in
the exhaled aerosol.”).
39. See Brown & Cheng, supra note 37, at ii6 (describing that micromechanical systems (MEMS)
that employ tiny pumps to deliver “specifically programmed quantities and combinations of e-liquids” the
user can control).
40. Id.
41. See Shu-Hong Zhu et al., Four Hundred and Sixty Brands of E-Cigarettes and Counting:
Implications for Product Regulation, 23 TOBACCO CONTROL (SUPP. ISSUE 3) iii3, iii4–5 (July 2014),
http://tobaccocontrol.bmj.com/content/tobaccocontrol/23/suppl_3/iii3.full.pdf
(following
two
comprehensive internet searches researchers identified 466 unique e-cigarette brands as of January 2014).
42. Grana et al., supra note 16 at 13.
43. See Chen et al., supra note 4, at 356.
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developed, the e-liquid market expanded to meet—and increase—demand.44 As
of 2014, e-liquid was available in more than 7,700 flavors.45 In fact, with the
rise of vape shops—specialty stores that sell ENDS products and e-liquid—there
is an unlimited number of flavors as “mixologists” can create blends or unique
flavors upon request and consumers can mix their own at home.46 Beyond flavor,
the e-liquid market is also diverse with respect to nicotine content, with some eliquid marketed as nicotine-free and others listing nicotine concentration,
ranging from 0 to 36 mg/mL.47 The accuracy of the nicotine level listed for eliquid is in serious doubt, at least in the pre-FDA regulation era.48 Research
shows great variation in nicotine content, with some nicotine-free products
testing as containing some amounts of nicotine and with a large %age of products
with nicotine levels higher or lower than the listed amount.49 And little is known
about the chemical content of e-liquid, there being no ingredient disclosure
requirements.50 E-liquid is available in vials, bottles and “even the barrel.”51
The changes in ENDS and e-liquid result in—and perhaps from—changes
in the marketing of the products. The early first generation of closed system
ENDS were generally quite expensive and available only in mall kiosks and
online.52 A rechargeable, closed-system Smoking Everywhere product
purchased by the Legal Resource Center in the mid-2000s cost $175 and was
purchased at a suburban mall kiosk in Maryland. Quickly, however, cheaper
versions of the product were produced and marketed alongside cigarettes and
other tobacco products at convenience stores, gas stations, pharmacies, and more.

44. See Shu-Hong Zhu, supra note 41, at iii5 (2014) (noting that 242 new flavors were added per
month during the study).
45. See id. at iii5 .
46. See Jean-François Etter, Levels of Saliva Cotinine in Electronic Cigarette Users, 109 ADDICTION
825, 828 (2014) (stating that some users mixed their own ‘home-made’ e-liquid with ingredients
purchased online); see Christian McPhate, Dark Clouds on E-Cigs’ Horizon Have Arrived, DALLAS
OBSERVER (Oct. 31, 2016), http://www.dallasobserver.com/news/dark-clouds-on-e-cigs-horizon-havearrived-8853795 (explaining that many vape shops have mixed e-liquids in their backrooms using food
additives and nicotine).
47. See McRobbie, supra note 17, at 8.
48. See Maciej L. Goniewicz et al., Nicotine Levels in Electronic Cigarette Refill Solutions: A
Comparative Analysis of Products From the US, Korea, and Poland, 26 INT’L J. DRUG POL’Y 583, 585
(2015) (describing a study that found that US e-liquid products showed significant differences between
the labelled and detected nicotine).
49. See id. at 585.
50. See id. at 584 (explaining that currently the FDA has no authority to require ENDS manufacturers
to disclose product ingredients, but predicting that the FDA will deem ENDS as tobacco products and
bringing them within the scope of FDA regulation).
51. Nathan K. Cobb et al., Novel Nicotine Delivery Systems and Public Health: The Rise of the “ECigarette”, 100 AM. J. PUB. HEALTH 2340, 2340 (2010) (explaining that some e-liquid is sold in bottles);
Matt Richtel, Selling a Poison by the Barrel: Liquid Nicotine for E-Cigarettes, N.Y. TIMES (Mar. 23,
2014), https://www.nytimes.com/2014/03/24/business/selling-a-poison-by-the-barrel-liquid-nicotine-fore-cigarettes.html?_r=1 (noting that e-liquid is sold in various amounts, from vials to barrels).
52. 2016 SURGEON GENERAL’S REPORT: E-CIGARETTE USE AMONG YOUTH AND YOUNG ADULTS,
CDC (2016), at 14, 155, https://www.cdc.gov/tobacco/data_statistics/sgr/e-cigarettes/index.html.
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This took the product from the unique, high-cost category into the more
affordable, easily-accessible category. By contrast, a disposable cherry e-hookah
purchased by the Legal Resource Center in the early 2010s was approximately
$5 and available in a convenience store where cigarettes and other tobacco
products were sold. And ultimately, changes in the product sparked the
emergence of the vape shop where consumers can buy different reusable, opensystem ENDS devices and try innumerable flavors, including special mixes
blended in the vape shop.53 As with many consumer products, ENDS are often
purchased
online.54
The diverse ENDS market is somewhat bifurcated now. Closed system
ENDS often available in convenience stores tend to be marketed by cigarette
manufacturers.55 For example, Blu, a very popular rechargeable closed-system
cig-alike was first produced by Lorillard Tobacco Company and is now produced
by Imperial Tobacco.56 Open-system ENDS devices and e-liquid, on the other
hand, are made and distributed by any number of companies, many by small
entrepreneurs.57 These vendors are organized by a trade association, the SmokeFree Alternatives Trade Association, or SFATA, which estimates that there are
22 manufacturers of hardware, 13 assemblers of devices, more than 1200
manufacturers and perhaps 15,000 vape shops across the country.58 SFATA
believes that small and mid-sized business dominate the ENDS market, pushing
back against the belief that “Big Tobacco” is leading the charge in support of
ENDS.59
The dynamic evolution of ENDS makes one thing clear—there is no
“typical” ENDS product. Given the nascent nature of the product line, the
increasing use of ENDS and the high-tech nature of the more modern devices, it

53. See What Is A Vapeshop, BILLOWBY, https://billowby.com/blogs/learn/what-is-a-vapeshop (last
visited Feb. 20, 2017) (reporting that at first vape shops started as an outgrowth of traditional tobacconists,
but popularity increased to allow for expanded product lines, and vape shops appeared with different
mixes of flavors).
54. See Yadira Galindo, Online E-cigarette Vendors Engage Customers Using Popular Internet
Tools,
UC
SAN
DIEGO
NEWS
CTR.
(Oct.
2,
2015),
http://ucsdnews.ucsd.edu/pressrelease/online_e_cigarette_vendors_engage_customers_using_popular_in
ternet_tools (reporting that online sales comprise 25-30% of the $2 billion annual e-cigarette market).
55. Mike Esterl, Big Tobacco’s E-Cig Push gets a Reality Check, MARKETWATCH (Aug. 26, 2014,
3:59 PM), http://www.marketwatch.com/story/big-tobaccos-e-cig-push-gets-a-reality-check-2014-08-26154855951 (reporting that Altria group Inc. and Reynolds American Inc. quickly captured convenience
store sales of closed-system “cigalikes”).
56. See Brian Solomon, Reynolds, Lorillard Dump Blu E-cigarettes In $27 Billion Merger, FORBES
(Jul. 15, 2014, 2:53 PM), http://www.forbes.com/sites/briansolomon/2014/07/15/reynolds-lorillarddump-blu-e-cigarettes-in-27-billion-merger/#733d9b0bd1c6 (explaining the Lorillard sold Blu to
Imperial in 2014, after it merged with Reynolds).
57. See About SFATA, SMOKE-FREE ALTERNATIVES TRADE ASS’N, http://sfata.org/about-sfata/ (last
visited Feb. 20, 2017) (stating that the ENDS industry has provided over 70,000 jobs because of the recent
increase in ENDS companies).
58. Id.
59. Id.
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is impossible to surmise the future of ENDS. This, of course, frustrates
researchers who need time to study the impact of the product while the ticking
of time means the studied product has become altered or obsolete before the
study’s conclusion.
III. MARKET HISTORY AND SALES
ENDS sales have increased sharply since their introduction to the U.S.
market in 2007.60 From 2009 to 2014 annual sales increased from $39 million
to nearly $2 billion, with average sales more than doubling each year.61 The
growth rate slowed significantly in 2015, but sales still surpassed $3 billion.62
Preliminary estimates for 2016 exceed $4 billion and industry projections
indicate continued growth through at least 2023, when annual sales could surpass
$20 billion.63 The 2014-2015 market slowdown was accompanied by a dramatic
shift in the retail location and categories of products sold.64 Previously,
disposable “cig-alikes” purchased in convenience stores and other mass retail
establishments dominated the category.65 Beginning in 2014, however, opensystem personal vaporizers became the most widely purchased ENDS product.66
These refillable devices accounted for nearly two-thirds of all ENDS sales this
year.67 At the same time vape shops and online retailers continue to increase
their market share at the expense of convenience stores and other mass retail

60. See Kathleen Burke, The Government Crackdown is Here: What the FDA Regulations Mean for
E-cigarettes, MARKETWATCH (Aug. 8, 2016, 10:21 AM), http://www.marketwatch.com/story/thegovernment-crackdown-is-here-what-the-fda-regulations-mean-for-e-cigarettes-2016-05-05.
61. See E-Cigarette Use Among Youth Adults: A Report of the Surgeon General, U.S. DEP’T OF
HEALTH
AND
HUM.
SERV.
152–153(2016),
https://ecigarettes.surgeongeneral.gov/documents/2016_SGR_Full_Report_non-508.pdf.
62. See Susan Adams, Can E-Cigarettes Survive The War Against Vaping, FORBES (May 5, 2016,
10:56 AM), http://www.forbes.com/sites/susanadams/2016/05/05/can-e-cigarettes-survive-the-waragainst-vaping/#39f7059269b2 (commenting that the size of the U.S. e-cigarette industry exceeded $3
billion sales in 2015, but that sales in convenience stores and big retailers shrunk 6.2 %).
63. See Susan Adams, E-Cigarette Manufactures Say New Regulations Will Devastate the Industry,
FORBES (May 5, 2016, 3:01 PM), http://www.forbes.com/sites/susanadams/2016/05/05/e-cigarettemanufacturers-say-new-regulations-will-devastate-the-industry/#3bdcd27730bb (estimating that that the
e-cigarette industry was worth just under $4 billion dollars last year); BIS RESEARCH, Global E-Cigarette
& Vaporizer, Device and Aftermarket, Analysis and Forecast, 2016-2025, RES. & MARKETS (Sept. 2016),
http://www.researchandmarkets.com/reports/3845485/global-e-cigarette-and-vaporizer-device-and
(predicting that the e-cigarette market will grow to $47 billion by 2025).
64. See Mike Esterl, Big Tobacco’s E-Cig Push Gets a Reality Check, MARKETWATCH (Aug. 26,
2014, 3:59 PM), http://www.marketwatch.com/story/big-tobaccos-e-cig-push-gets-a-reality-check-201408-26-154855951 (documenting a shift in the e-cigarette market to “vape shops”).
65. See id. (connecting the decrease in e-cigarette convenience store sales to an increase in the vape
shop market).
66. See Open System Vaporizers Officially Overtake E-Cigs, Top $1 Billion in Sales for the FirstTime Ever, MARKETWATCH (Sept. 25, 2014), http://www.marketwatch.com/story/open-systemvaporizers-officially-overtake-e-cigs-top-1-billion-in-sales-for-the-first-time-ever-2014-09-25.
67. See U.S. DEP’T OF HEALTH AND HUM. SERV., supra note 61, at 150.
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channels.68 Combined, these emerging retail channels account for 70 % of all
ENDS
sales.69
Total ENDS sales pale in comparison to the domestic cigarette market,
which exceeds $100 billion annually, but the ENDS market is growing at a faster
rate.70 In 2015, convenience store sales grew more than 7 % for ENDS versus 3
% for cigarettes, and convenience stores represent the smallest retail market for
ENDS.71 While cigarette sales still represent 32 % of all convenience store sales
– the largest share of any product – sales have been declining for a quartercentury.72 The 3 % growth last year was followed by 5 straight years of decline.73
The timing of this growth raises the question of whether dual use of ENDS and
cigarettes is contributing to the renewed cigarette sales growth.

IV. WHO IS USING ENDS?
A. Adult Use
As the retail sales data indicate, ENDS use is increasing rapidly.74 The
Centers for Disease Control and Prevention estimate that 1 in 8 adults age 18
years or older have ever used ENDS, a threefold increase over the past two years,

68. See Esterl, supra note 64 (documenting the decrease in convenience store sales in comparison to
vape shop and online sales).
69. See Martinne Geller, Special Report: When it Comes to E-Cigs, Big Tobacco is Concerned for
your Health, REUTERS (Mar. 23, 2015, 1:52 PM), http://www.reuters.com/article/us-ecigarettesregulations-specialreport-idUSKBN0MJ0GN20150323.
70. See Tripp Mickle, E-Cigarette Sales Rapidly Los Steam, WALL ST. J. (Nov. 17, 2015, 7:15 PM),
http://www.wsj.com/articles/e-cig-sales-rapidly-lose-steam-1447798921 (explaining that, cigarette
volumes are down 0.5% in 2015 while ENDS have grown 114% in the past five years).
71. See Where The Gains Are, CSP (Apr. 15, 2016), http://www.cspdailynews.com/categorydata/cmh/tobacco/tobacco-cigarettes-2016 (reporting the growth in unit sales for cigarettes and electronic
smoking devices); see also Study Shows Shopping Habits of E-Cig Users, CONVENIENCE STORE
DECISIONS (Aug. 9, 2016), http://www.cstoredecisions.com/2016/08/09/study-shows-shopping-habits-ecig-users/ (stating that only 8% of polled respondent bought ENDS products at a “convenience store”).
72. See Samantha Oller, Preliminary Overview Data From NACS State Of The Industry Summit 2016,
CSP DAILY NEWS (May, 2016), http://www.cspdailynews.com/print/csp-magazine/article/preliminaryoverview-data-nacs-state-industry-summit-2016 (finding cigarettes accounted for $50,367 of $156,411
total in store sales, equaling roughly 32%); see also Convenience Stores: Keep the Core; Appeal to More,
TIMES
&
TRENDS,
https://www.iriworldwide.com/iri/media/iriclients/T_T%20May%202013%20Convenience%20Stores%2006042013.pdf (last visited Mar. 10, 2017)
(noting that volume sales in convenience stores are down sharply and identifying as the primary factor
that the smoking rate has declined 50% since 1965).
73. Salynn Boyles, Convenience Store Cigarette Sales Grew in 2015, MEDPAGE TODAY (Mar. 10,
2017), https://www.medpagetoday.com/pulmonology/smoking/63753.
74. King, Brian A.et al., Trends In Awareness And Use Of Electronic Cigarettes Among US Adults,
2010–2013, NICOTINE TOBACCO RES. 17.2 (2015): 220 (finding awareness and use of e-cigarettes
through enhanced marketing is rapidly increasing).
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and 1 in 20 use ENDS regularly.75 Age and smoking status are the best predictors
of ENDS use. Nearly 1 in 4 adults age 18-24 years have ever used ENDS, with
use declining steadily as age increases.76 Differences across age groups were
even more defined when examining non-smoking ENDS users.77 Nearly half of
current cigarette smokers and more than half of former cigarette smokers have
ever used ENDS.78 Those cigarette smokers actively attempting to quit were also
twice as likely as other smokers to have tried ENDS.79 These data indicate older
adults are using ENDS to quit smoking, while the majority of young adult (1824) ENDS users are never-smokers.
B. Youth Use
While cigarette smoking rates among high school youth have decreased
significantly over the past quarter-century (28% in 1991 to 11% in 2015)80, an
estimated 5.6 million Americans currently under the age of 18 are still projected
to die prematurely from a smoking-related disease.81 Moreover, the rate of
decline has slowed in recent years, and one recent national survey showed a
slight increase in cigarette smoking among high school youth between 2014 and
2015 (9.2% to 9.3%).82 There is growing concern that the slowing decline in
youth cigarette smoking rates is associated with the increased prevalence of
ENDS use. Since 2011, youth ENDS use has skyrocketed, particularly among

75. CHARLOTTE A. SCHOENBORN & RENEE M. GINDI, U.S. DEP’T OF HEALTH & HUMAN SERVICES,
NCHS DATA BRIEF NO. 217, ELECTRONIC CIGARETTE USE AMONG ADULTS: UNITED STATES, 2014
(2015), https://www.cdc.gov/nchs/data/databriefs/db217.pdf (finding that 12.6% of adults had tried an ecigarette and 3.7% use them everyday); see also id. at 223 (reporting that 3.3% adults had ever used ENDS
in 2010).
76. See Schoenborn & Gindi, supra note 75 (finding 21.6% of those aged 18-24 have used an ENDS
product with use declining steadily as age increases).
77. See id. at 5 (reporting that 9.7% of adults aged 18-24 had tried an electronic cigarette despite
having never tried a traditional cigarette compared to 4.9% of all adults over the age of 24).
78. Id.
79. See id. (finding 20.3% of those adults who had attempted to quit in the past year had tried an
electronic cigarette compared to 11.8% of cigarette smokers who had not tried to quit).
80. Current Cigarette Smoking Among U.S. High School Students Lowest in 24 years, NAT’L YOUTH
RISK BEHAV. SURVEYS, 1991–2015, http://www.cdc.gov/media/dpk/healthy-living/youth-risk-behaviorsurvey/images/yrbs_release_graphics_smoking_2016.pdf (last visited Feb. 20, 2017).
81. Youth
and
Tobacco
Use,
CDC,
http://www.cdc.gov/tobacco/data_statistics/fact_sheets/youth_data/tobacco_use/index.htm (last updated
Apr. 14, 2016).
82. See Tushar Singh et al., Tobacco Use Among Middle and High School Students—United States,
2011–2014, 64 MORBIDITY & MORTALITY WKLY. REP. 381, 385 (2015) (finding that 9.2% of high school
students used cigarettes in 2014); see also Tushar Singh et al., Tobacco Use Among Middle and High
School Students—United States, 2011–2015, 65 MORBIDITY & MORTALITY WKLY. REP. 361, 366 (2016)
(finding that 9.3% of high school students used cigarettes in 2015).
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high school students.83 From 2011 to 2015 ENDS “ever-use” increased from
less than 1 in 20 (4.5%) to nearly 1 in 2 (44.9%) among U.S. high school students,
and “current-use” increased from 1 in 100 (1.5%) to 1 in 4 (24.1%).84 ENDS are
now the most commonly used tobacco product among high school students, at
more than double the rate of cigarettes (24.1% to 10.8%).85 Moreover, youth
ENDS users are significantly more likely to transition to cigarette smoking than
youth non-users.86 Recent studies indicate that among “never-smokers,” youth
ENDS users were 2 to 4 times more likely than non-users to (1) initiate cigarette
smoking or (2) intend to smoke cigarettes in the future.87
In contrast to adults, most youth ENDS users have never smoked cigarettes.
If kids are experimenting with ENDS and transitioning to cigarettes or other
conventional tobacco products the adverse impact on population health could
reverberate for decades. Therefore, when crafting ENDS regulations any
potential benefits ENDS provide to adult users must be weighed against the
83. E-cigarette Use Triples Among Middle and High School Students in Just One Year, CDC
NEWSROOM, http://www.cdc.gov/media/releases/2015/p0416-e-cigarette-use.html (last visited Feb. 20,
2017).
84. Notes from the Field: Electronic Cigarette Use Among Middle and High School Students – United
States, 2011-2012, 62 MORBIDITY & MORTALITY WKLY. REP. 729, 729 (2013) (finding that in 2011, 4.7%
of high school students had ever used e-cigarettes and 1.5% currently used them); see also Youth Risk
Behavior Surveillance – United States, 2015, 65 MORBIDITY & MORTALITY WKLY. REP. 1, 17 (2016)
(finding that in 2015, 24.1% of high school students currently use electronic vapor products and 44.9%
had ever used them).
85. Youth Risk Behavior Surveillance – United States, 2015, supra note 84, at 81, 91.
86. See Adam M. Leventhal et al., Association of Electronic Cigarette Use With Initiation of
Combustible Tobacco Product Smoking in Early Adolescence, 314 JAMA 700, 707 (2015) (noting that
high school students in Los Angeles who used e-cigarettes were more likely than those who never used ecigarettes to report initiation of combustible tobacco use).
87. See, e.g., Rebecca Bunnell et al., Intentions to Smoke Cigarettes Among Never-Smoking US
Middle and High School Electronic Cigarette Users: National Youth Tobacco Survey, 2011-2013, 17
NICOTINE TOBACCO RES. 228, 233 (2015) (reporting that youth who used electronic cigarettes were twice
more likely to have intentions to smoke regular cigarettes than youth who never smoked electronic
cigarettes); see also Victor M. Cardenas et al., Use of Electronic Nicotine Delivery Systems and Recent
Initiation of Smoking Among US Youth, 61 INT’L J. PUB. HEALTH 237, 239 (2016) (finding that the use of
electronic cigarettes was associated with recent initiation of cigarette smoking among youth); see also
Leventhal et al., supra note 86, at 706 (noting that high school students in Los Angeles who used ecigarettes were more likely than those who never used e-cigarettes to report initiation of combustible
tobacco use); see also Ji-Yeun Park et al., E-Cigarettes Use and Intention to Initiate or Quit Smoking
Among US Youths, 106 AM. J. PUB. HEALTH 672, 675 (2016) (finding that youth who used electronic
cigarettes were more likely to have intention to smoke cigarettes than youth who had never used electronic
cigarettes);see also Brian A. Primack et al., Progression to Traditional Cigarette Smoking After Electronic
Cigarette Use Among US Adolescents and Young Adults, 169 JAMA PEDIATRICS 1018, 1022 (2015)
(identifying an association between use of electronic cigarettes and progression to traditional cigarette
smoking among youth);see also Jessica L. Barrington-Trimis et al., E-Cigarettes and Future Cigarette
Use, 138 PEDIATRICS 1, 6 (2016) (reporting that youth that used electronic cigarettes were six times more
likely of initiating cigarette than youth who never used electronic cigarettes); see also Thomas A.Wills et
al., Longitudinal Study of E-cigarette Use and Onset of Cigarette Smoking Among High School Students
in
Hawaii,
TOBACCO
CONTROL
5
(Jan.
25,
2016),
http://tobaccocontrol.bmj.com/content/early/2016/01/05/tobaccocontrol-2015-052705.abstract
(concluding that youth who uses electronic cigarettes are more likely to start smoking cigarettes).
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V. HEALTH EFFECTS
Since ENDS are relatively new to the market, the long-term health effects
are still largely unknown.88 The absence of federal regulation and the large
variance in ingredients and toxicant concentrations across brands likewise makes
the toxicity of these products difficult to quantify.89 However, the limited clinical
research conducted to this point indicates that ENDS contain carcinogens and
toxic chemicals, albeit at lower levels than cigarettes. In 2009, FDA analyzed
numerous ENDS products and found they contained carcinogens, including
nitrosamines, and “toxic chemicals such as diethylene glycol, an ingredient used
in anti-freeze.”90 More recent clinical studies indicate dozens of e-liquid brands
contain a litany of dangerous toxicants, including, “propylene glycol, glycerin,
tobacco specific nitrosamines, tobacco alkaloids, carbonyls, ethylene glycol,
diacetyl, andacetyl propionyl. . .heavy metals, and volatile organic
compounds.”91 While some studies have found lower toxicant levels in ENDS
aerosol than combustible tobacco, the levels frequently exceeded existing federal
occupational safety limits on exposure to these chemicals.92 Moreover, nicotine,
the key ingredient in most e-liquid, is highly addictive, has immediate biochemical effects on the brain and body and is toxic in high doses.93
In 2011, the National Institutes of Health (NIH) and FDA announced a joint
study called the Population Assessment of Tobacco and Health study (PATH),
which will analyze tobacco use behaviors, including ENDS use, among 46,000
Americans age 12 years and older.94 In addition, NIH-FDA are jointly funding
Tobacco Centers of Regulatory Science (TCORS) at fourteen academic research

88. 42 C.F.R. §59.203 (2017).
89. See E-cigarettes and Lung Health, AM. LUNG ASSOC., http://www.lung.org/stopsmoking/smoking-facts/e-cigarettes-and-lung-health.html (last visited Feb. 20, 2017) (explaining that
varying toxin levels in e-cigarette aerosols is one of the reasons the American Lung Association is calling
for FDA oversight of e-cigarettes).
90. FDA and Public Health Experts Warn About Electronic Cigarettes, FDA (July 22, 2009),
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm173222.htm.
91. 42 C.F.R. §59.203 (2017) (responding to rule comment on toxicity of e-cigarettes).
92. See id. at 29,032 (explaining that the FDA recognizes that aerosol exhaled by e-cigarette users
may be less harmful that smoke from combustible tobacco); see also Konstantinos E. Farsalinos et al.,
Evaluation of Electronic Cigarette Liquids and Aerosol for the Presence of Selected Inhalation Toxins,
17 NICOTINE & TOBACCO RES. 168, 170–71 (2015) (reporting the presence of diacetyl and acetyl
propionyl in levels higher than National Institute for Occupational Safety and Health safety limits).
93. U.S. DEP’T OF HEALTH AND HUMAN SERVICES, THE HEALTH CONSEQUENCES OF SMOKING:
NICOTINE ADDICTION: A REPORT OF THE SURGEON GENERAL 6–16 (Thomas E. Novotny & William R.
Lynn eds., 1988), https://profiles.nlm.nih.gov/ps/access/NNBBZD.pdf.
94. FAQs for Researchers, POPULATION ASSESSMENT OF TOBACCO & HEALTH,
https://pathstudyinfo.nih.gov/UI/FAQsResMobile.aspx (last visited Feb. 19, 2017).
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centers to determine the toxicity and health effects associated with tobacco
products, including ENDS.95 These TCORS are expected to contribute
substantially to the evidence-base FDA will use to inform its decision-making
on ENDS regulation and ultimately reduce tobacco-related death and disease in
the United States.96
A. Dual Use
Regardless of age, concomitant ENDS and cigarette use, commonly
referred to as “dual use,” presents a growing public health concern.97 National
surveys show that a significant number of adult and youth ENDS users are also
using traditional cigarettes.98 In fact, more than 3 in 4 current ENDS users, adult
and youth, are also current cigarette smokers.99 Many tobacco users believe that
cutting down on cigarette smoking by adding another tobacco product, such as
ENDS, reduces health risks.100 However, dual use leads to increased exposure
to toxicants, and may be associated with an increased risk of negative health
outcomes, including: cardiovascular disease, pancreatic and esophageal cancers,

95. See Centers Research Portfolio, NIH, https://prevention.nih.gov/tobacco-regulatory-scienceprogram/research-portfolio/centers (last visited Feb. 19, 2017) (informing of the collaborative effort
between the Tobacco Regulatory Science Program and the Food and Drug Administration Center for
Tobacco Products to conduct research in order to assist with the development of regulations); see also
Notice of Intent to Publish a Funding Opportunity Announcement for Tobacco Centers of Regulatory
Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act, NIH,
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-151.html (last visited Feb. 19, 2017)
(explaining that the purpose of the program, in part, is to study the toxicity and health effects of tobacco
products).
96. Id.
97. See
Dual
Use
of
Tobacco
Products,
CDC,
http://www.cdc.gov/tobacco/campaign/tips/diseases/dual-tobacco-use.html (last visited Feb. 19, 2017)
(explaining that dual use is not an effective way to safeguard health even when using less cigarettes yet
adding other tobacco products).
98. See Notes from the Field: Electronic Use Among Middle and High School Students – United
States, 2011-2012, 62 MORBIDITY & MORTALITY WKLY. REP. 729, 729 (2013) (reporting that among
middle school and high school students current use of both e-cigarettes and conventional cigarettes
increased); see also Schoenborn & Gindi, supra note 75, at 6 (stating that use of e-cigarettes was highest
among current and former cigarette smokers).
99. See CDC, supra note 97 (reporting 76.3% youth that currently uses e-cigarettes also uses
conventional cigarettes); see also Brian A. King et al., Trends in Awareness and Use of Electronic
Cigarettes Among US Adults, 2010–2013, 17 NICOTINE & TOBACCO RES. 219, 224 (2015), available at
https://academic.oup.com/ntr/article/17/2/219/2858030/Trends-in-Awareness-and-Use-of-Electronic
(reporting 76.8% of adults that currently uses e-cigarettes also uses conventional cigarettes).
100. See Pratibha Nayak et al., A Qualitative Study of Vape Shop Operators’ Perceptions of Risks and
Benefits of E-Cigarette Use and Attitude Toward Their Potential Regulation by the US Food and Drug
Administration, Florida, Georgia, South Carolina, or North Carolina, 2015, 13 PREVENTING CHRONIC
DISEASE 1, 3 (2016) (reporting on how sellers of ENDS products stated that customers used ENDS for
“lifestyle factors, including health and disease conditions…”).
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and inflammatory bowel disease.101 Moreover, light smoking (1-4 cigarettes per
day) and non-daily smoking are still associated with a significantly higher risk
of cancer, COPD, and heart disease.102 The only effective way to reduce the
health risks associated with smoking is to quit.103 Dual use commonly prevents,
rather than assists, smokers from quitting, and as such presents an obstacle to
reducing the health risks associated with cigarette smoking.104 Future ENDS
research must focus on whether the devices promote cessation or dual use, and
policy initiatives should seek to prevent dual use.
B. Cessation
Central to the debate surrounding ENDS is the potential for these devices
to assist cigarette smokers to quit. As indicated by their increasing popularity
among current and former smokers, a significant proportion of adult ENDS users
report using the devices to attempt to quit.105 In fact, less than 3 % of adult nonsmokers age 25–64 years old have ever tried ENDS, compared to more than 50
% of current and former smokers.106 It’s clear that cigarette smokers more
commonly use ENDS, and that they primarily use the devices in an attempt to
quit smoking, but do ENDS actually assist with smoking cessation? We don’t
know.
What we do know is that ENDS are not approved smoking cessation
devices. FDA has approved a variety of smoking cessation products, including
prescription medications, skin patches, lozenges, and gum.107 These approved
products have been subject to rigorous pre-market review required in the

101. Lucy Popova & Pamela Ling, Alternative Tobacco Product Use and Smoking Cessation: A
National Study, 103 AM. J. PUB. HEALTH 923, 923 (2013).
102. Rebecca E. Schane et al., Health Effects of Light and Intermittent Smoking, 121 J. AM. HEART
ASS’N 1518, 1519–20 (2010).
103. See
Quitting
Smoking,
CDC,
http://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/quitting/ (last updated Feb. 1, 2017)
(“People who stop smoking greatly reduce their risk for disease and early death.”).
104. Dual Use of Tobacco Products, CDC, http://www.cdc.gov/tobacco/campaign/tips/diseases/dualtobacco-use.html (last updated Jan. 23, 2017).
105. See Schoenborn & Gindi, supra note 75, at 3 (indicating that e-cigarettes are much more popular
among current and recent former smokers than long-term former smokers and never smokers); see also
Terry F. Pechacek et al., The Potential That Electronic Nicotine Delivery Systems Can be a Disruptive
Technology: Results From a National Survey, 18 NICOTINE & TOBACCO RES. 1989, 1994 (2016) (reporting
that “data suggest[s] that about 2.4 million former smokers perceived that the use of ENDS may have
helped in quitting use of regular cigarettes,”).
106. Schoenborn & Gindi, supra note 75, at 3.
107. U.S. DEPT. OF HEALTH & HUMAN SERV., INNOVATIVE PRODUCTS AND TREATMENTS TO
ACHIEVE ABSTINENCE FROM TOBACCO USE, REDUCTIONS IN CONSUMPTION OF TOBACCO, AND
REDUCTIONS IN THE HARM ASSOCIATED WITH CONTINUED TOBACCO USE (2013), available at
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/UCM348930.pdf.
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FDCA.108 ENDS are not among these approved products and no ENDS
manufacturer has submitted their product to FDA for evaluation or approval.109
We also know that the clinical studies conducted to this point indicate that
there is significant uncertainty about the efficacy of ENDS as cessation
devices.110 This uncertainty is largely the result of poor study methodology.
Most existing studies are limited by a lack of randomized trials, small sample
sizes, poor survey design, and/or variance in outcome measures.111 Moreover,
the rapid evolution of the devices and the lack of standardization in the devices
and e-liquid make long-term study virtually impossible; as soon as one product
is subject to significant study, it is essentially obsolete.112 The majority of
published, peer-reviewed studies, however, demonstrate a positive association
between
ENDS
and
smoking
cessation.113
The potential for ENDS as smoking cessation devices cannot be easily
brushed aside. An estimated 480,000 Americans die each year from cigarette
smoking-related illness.114 Any product that has the potential to reduce the
number of cigarette smokers must be examined. ENDS cessation research is still
in its early stages, and there is a need for more carefully designed and
methodically sound studies to determine whether and how these devices may be
helpful.

108. See id. (explaining that FDA’s premarket approval process applies to products that aim to treat
or cure tobacco dependence).
109. Electronic
Cigarettes,
BETOBACCOFREE.GOV,
http://betobaccofree.hhs.gov/abouttobacco/Electronic-Cigarettes (last visited Feb. 19, 2017); see also Medical Device Databases; Premarket
Approval, FDA, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMA/pma.cfm (last visited Feb. 19,
2017) (demonstrating how as of Feb. 8, 2017 no ENDS product appears to have been submitted to the
FDA for approval for smoking cessation).
110. Muhannad Malas et al., Electronic Cigarettes for Smoking Cessation: A Systematic Review, 18
NICOTINE & TOBACCO RES. 1926, 1927 (2016).
111. Id. at 1927, 1931.
112. See Barbara Davis et al., Nicotine Concentrations in Electronic Cigarette Refill and Do-ItYourself Fluids, 17 NICOTINE & TOBACCO RES. 134, 139–40 (2015) (discussing the variability of nicotine
concentrations and colors in identical refill cartridges and calling for greater standardization in the
manufacturing process); see also Farsalinos et al., supra note 14, at 6 (arguing that Electronic Cigarette
“technology is progressing at a fast pace and research is sometimes unable to follow this progress and
assess the efficacy of such devices promptly.”). (explaining that Electronic Cigarette “technology is
progressing at a fast pace and research is sometimes unable to follow this progress and assess the efficacy
of such devices promptly.”).
113. Malas et al., supra note 110, at 1931–32 (finding that limited evidence seems to indicate that ecigarettes may be useful to help some smokers quit).
114. Fast Facts, CDC, http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/ (last
updated Dec. 20, 2016).
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VI. REGULATORY HISTORY
A. Tobacco Regulation Prior to 1996
Prior to 1996, a hodgepodge of federal, state and local laws governed the
cultivation, manufacture, advertising and promotion, distribution, and sale of
tobacco products. The issue of tobacco and health was directly regulated by
Congress primarily through six federal statutes: the Federal Cigarette Labeling
and Advertising Act (1965), the Public Health Cigarette Smoking Act of 1969,
the Alcohol and Drug Abuse Amendments of 1983, the Comprehensive Smoking
Education Act (1984), the Comprehensive Smokeless Tobacco Health Education
Act (1986), and the Alcohol, Drug Abuse, and Mental Health Administration
Reorganization Act (1992).115 These statutes established advertising and
packaging health warnings, prohibited radio and television advertisements116,
required the Secretary of Health and Human Services (HHS) to submit a triennial
report on “the addictive property of tobacco117,” and made receipt of federal
substance abuse block grant dollars contingent on states enacting and enforcing
minimum purchase age restrictions.118 Many state and local governments
115. See generally, e.g., Federal Cigarette Labeling and Advertising Act, Pub. L. No. 89–92, 79 Stat.
282 (1965) (codified at 15 U.S.C. §§ 1331–1340) (generally providing for national standards on cigarette
packaging); see also Public Health Cigarette Smoking act of 1969, Pub. L. No. 91–222, 84 Stat. 87 (1970)
(requiring stronger warning language on cigarette packaging and banning cigarette advertising on
television and radio); see also Alcohol and Drug Abuse Amendments of 1983, Pub. L. No. 98–24, 97 Stat.
175 (1983) (establishing a new title called the Administration and Coordination of the National Institute
of Mental Health, the national institute on Alcohol Abuse and Alcoholism, and the National Institute on
Drug Abuse); see also Comprehensive Smoking Education Act, Pub. L. No. 98–474, 98 Stat. 2200 (1984)
(amending the Federal Cigarette Labelling and Advertising Act to create a rotational label warning system,
requiring cigarette packages and advertisements to rotate through four different warnings every three
months); see also Comprehensive Smokeless Tobacco Health Education Act of 1986, Pub. L. No. 99–
252, 100 Stat. 30 (1986) (requiring health warnings on all packages and advertisements for smokeless
tobacco); see also Alcohol, Drug, Abuse and Mental Health Administration Reorganization Act, Pub. L.
No. 102–321 § 202, 106 Stat. 394 (1992) (substantially amending the Public Health Service Act to replace
provisions relating to the Alcohol, Drug Abuse and Mental Health Administration, the National Institute
on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse and the National Institute of
Mental Health.).
116. 15 U.S.C. §§ 1331 (1994) (stating Congress’s policy to inform the public about any potentially
negative health effects of smoking, using labeling and advertising regulations); 1333 (1994) (mandating
that cigarette packages, cigarette advertisements, and outdoor billboards advertising cigarettes must have
a Surgeon’s General Warning on them); 4402(a) (1994) (requiring that smokeless tobacco products carry
a label warning of its potential health consequences). They also prohibit the advertisement of tobacco
products through “any medium of electronic communication” subject to regulation by the Federal
Communications Commission (FCC). 15 U.S.C. § 1335 (1994) (prohibiting advertisements of cigarettes
or little cigars on electronic communications); 4402(d) (1994) (requiring manufacturers, packagers, or
importers of smokeless tobacco products to submit a plan to the FTC specifying how they will comply
with 4402(a)).
117. 42 U.S.C. § 290aa(b)(2) (1994) (requiring the Secretary of HHS to report every three years to
Congress on certain research findings concerning “the addictive property of tobacco.”).
118. 42 U.S.C. § 300x-26(a)(1) (1994) (making the States’ receipt of certain federal block grants
contingent on their making it unlawful “for any manufacturer, retailer, or distributor of tobacco products
to sell or distribute any such product to any individual under the age of 18.”).
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supplemented federal laws by imposing tobacco excise taxes, establishing
licensing and zoning restrictions on the manufacture and distribution of tobacco
products, and limiting the use of lighted tobacco products on public
transportation and in government buildings.119 However, no federal agency was
granted express regulatory authority over tobacco products and enforcement was
divided among several agencies, including, the Alcohol and Tobacco Tax and
Trade Bureau120; Bureau of Alcohol, Tobacco, Firearms, and Explosives121;
Federal Communications Commission122; Federal Trade Commission123; and
Substances Abuse and Mental Health Services Administration.124
Given its expansive drug authority, the U.S. Food and Drug Administration
(FDA) was perhaps best-suited to comprehensively regulate tobacco, but for
decades disavowed jurisdiction.125 Under the Food, Drug, and Cosmetic Act
(FDCA), FDA has authority to regulate the safety of food, drugs, and
cosmetics.126 While originally intended to reduce abuses in the food and
cosmetics industries, the FDCA nonetheless contains powerful provisions
regulating “drugs,” “devices,” and “combination products.”127 These provisions
119. Julie A. Fishman et al., State Laws on Tobacco Control—United States, 1998, 48 MORBIDITY &
MORTALITY WKLY. REP. 21 (1999), http://www.cdc.gov/mmwr/preview/mmwrhtml/ss4803a2.htm.
120. TTB’s Mission – What We Do, ALCOHOL AND TOBACCO TAX AND TRADE BUREAU,
https://www.ttb.gov/consumer/responsibilities.shtml (last visited Feb. 22, 2017) (explaining that the
agency enforces the laws regulating tobacco manufacturing and importing business and deals mainly with
Federal excise taxes on tobacco products).
121. Alcohol & Tobacco, BUREAU OF ALCOHOL, TOBACCO, FIREARMS, & EXPLOSIVES,
https://www.atf.gov/alcohol-tobacco (last visited Feb. 22, 2017) (explaining that the ATF enforces laws
against contraband tobacco in interstate commerce).
122. Program Content Regulations, FED. COMM. COMM’N, https://www.fcc.gov/media/programcontent-regulations (last visited Feb. 22, 2017) (“Advertisements for cigarettes, little cigars and smokeless
tobacco are prohibited on any medium of electronic communication subject to the jurisdiction of the
Federal Communications Commission.”).
123. Federal
Trade
Commission
Cigarette
Report
for
2013,
FTC
(2016)
https://www.ftc.gov/system/files/documents/reports/federal-trade-commission-cigarette-report2013/2013cigaretterpt.pdf (enforcing advertising laws that govern tobacco products).
124. About the Synar Amendment and Program, SAMHSA, https://www.samhsa.gov/synar/about (last
visited Feb. 22, 2017) (describing SAMHSA’s role in implementing the Synar amendment, a law that
requires states to enact and enforce laws prohibiting the sale or distribution of tobacco products to minos).
125. See, e.g., 1972 Hearings 239, 242 (statement of Comm’r Edwards) (“[R]egulation of cigarettes is
to be the domain of Congress,” and “[a]ny such move by FDA would be inconsistent with the clear
congressional intent”); see also 1983 House Hearings 74 (statement of Assistant Secretary Brandt)
(explaining that FDA does not have the authority to regulate tobacco because it “is something that
Congress has reserved to itself”); see also 1983 Senate Hearings 56 (statement of Assistant Secretary
Brandt) (“Congress has assumed the responsibility of regulating the tobacco industry and regulating
cigarettes”).
126. See Food, Drug, and Cosmetic Act, Pub. L. No. 717, 52 Stat. 675 (1938) (establishing the Food
Drugs and Cosmetics act and granting authority to regulate food, drugs, devices, or cosmetics introduced
into interstate commerce).
127. See Food, Drug, and Cosmetic Act section 301, 501–505 (1938) (prohibiting adulterated and
misbranded drugs and devices and authorizing FDA to regulate them); See Safe Medical Devices Act of
1990 section 16 (amending the FDCA to authorize regulation of “products that constitute a combination
of a drug, device, or biological product.”).
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authorize FDA to regulate any non-food article (“drugs”) or instrument
(“devices”), or combination of the two (“combination products”) “intended to
affect the structure or any function of the body.”128 Moreover, the FDCA requires
warning labels and prohibits false and misleading therapeutic claims for all
drugs, devices, and combination products.129 The Act also requires premarket
approval for each, meaning a manufacturer must demonstrate to the agency that
the product is safe before it can be made commercially available.130
Tobacco leaves contain nicotine, a highly addictive alkaloid stimulant, and
a drug.131 Yet, from its inception in 1906 following passage of the Pure Food
and Drugs Act to 1994, FDA never asserted authority to regulate tobacco
products.132 In fact, the agency repeatedly testified before Congress that
cigarettes and other tobacco products were outside the scope of its statutory
authority “absent health claims establishing a therapeutic intent on behalf of the
manufacturer or vendor.”133 The agency even went so far as to argue that if
tobacco products were within its jurisdiction “they would have to be removed
from the market because it would be impossible to prove they were safe for their
intended us[e]” as required by the FDCA.134
128. 21 USC § 321(g), (h) (defining “drug” as “articles (other than food) intended to affect the
structure or any function of the body” and “device” as “an instrument, apparatus, implement, machine,
contrivance… intended to affect the structure or any function of the body.”); 21 USC § 353(g)(1)(A)
(describing combination products as “products that constitute a combination of a drug, device, or
biological product.”).
129. 21 U.S.C. § 352(a), (f) (2012) (deeming drugs or devices misbranded if the label is false or
misleading or if the label does not bear adequate warnings); 21 USC § 353(g)(1) (authorizing FDA to
regulate combination products).
130. See 21 U.S.C. § 360e (2012).
131. Nicotine
Addiction
and
Your
Health,
BETOBACCOFREE.GOV,
http://betobaccofree.hhs.gov/health-effects/nicotine-health/index.html (last visited Feb. 22, 2017)
(explaining that tobacco leaves contain nicotine, a highly addictive drug); see also Nicotine (Code C691),
NAT’L
CANCER
INST.
(Jan.
30,
2016),
https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus
&code=C691 (defining nicotine as a plant alkaloid and addictive central nervous system stimulant).
132. FDA v. Brown & Williamson Tobacco Corp., 529 U.S. 120, 158 (2000) (describing how the FDA
disavowed jurisdiction over tobacco products until 1994); Significant Dates in U.S. Food and Drug Law
History, FDA https://www.fda.gov/AboutFDA/WhatWeDo/History/Milestones/ucm128305.htm (last
updated Dec. 19, 2014) (explaining that FDA announced its decision to regulate nicotine in 1994 in
response to a Citizen’s petition by the Coalition on Smoking OR Health).
133. Brown & Williamson Tobacco Corp., 529 U.S. at 146 (citing Brief for Appellee (FDA) in Action
on Smoking and Health v. Harris, 655 F.2d 236 (C.A.D.C.1980), in 9 Rec. in No. 97–1604 (CA4), Tab
No. 4, pp. 14–15) (“In the 73 years since the enactment of the original Food and Drug Act, and in the 41
years since the promulgation of the modern Food, Drug, and Cosmetic Act, the FDA has repeatedly
informed Congress that cigarettes are beyond the scope of the statute absent health claims establishing a
therapeutic intent on behalf of the manufacturer or vendor”).
134. Public Health Cigarette Amendments of 1971: Hearings before the Commerce Subcommittee on
S. 1454, 92d Cong., 2d Sess., 239 (1972) (statement of FDA Comm’r Charles Edwards); see also Cigarette
Labeling and Advertising: Hearings before the House Committee on Interstate and Foreign Commerce,
88th Cong., 2d Sess., 18 (1964) (statement of Dept. of Health, Education, and Welfare (HEW) Secretary
Anthony Celebrezze) (explaining that FDA jurisdiction over smoking products “might well completely
outlaw at least cigarettes’’).
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B.FDA’s About-Face on Tobacco Products
In 1994, FDA announced it was considering regulating cigarettes and
smokeless tobacco under its FDCA authority; marking a dramatic shift in agency
policy after more than four decades of refusing to assert jurisdiction over tobacco
products.135 Earlier in the year, several health advocacy organizations submitted
citizen petitions to FDA urging the agency to regulate cigarettes containing
nicotine as drugs under the FDCA.136 FDA Commissioner David Kessler
responded by initiating an investigation to determine whether tobacco products
containing nicotine were properly within the scope of the agency’s drug
authority.137
The central question was whether nicotine meets the statutory definition of
“drug” under the FDCA.138 To satisfy the statutory definition, FDA had to
determine whether: (1) nicotine “affects the structure or any function of the
body” and (2) these effects were “intended” by the manufacturer.139 Intent could
be established by showing that a reasonable manufacturer would foresee the
pharmacologic effects of the product, consumers would use it for the
pharmacologic effects, or the manufacturer designs the products to be used for
its pharmacologic effects.140 Extensive scientific evidence conclusively
demonstrated that nicotine affects the structure or function of the body, because
it “causes and sustains addiction, and acts as a sedative, stimulant, and appetite
suppressant.”141 And, through its nearly 18-month investigation – led by then
Associate Commissioner and current Director of the Center of Tobacco Products
(CTP), Mitch Zeller – the agency also found that the pharmacological effects of
nicotine were intended by tobacco manufacturers based on all three statutory
criteria: (1) nicotine’s addictive properties were widely known; (2) nearly 90%
of users were addicted to nicotine, and 50% of youth users smoked or used
smokeless tobacco for the “buzz” or to lose weight; and (3) industry documents
demonstrated that tobacco manufacturers were not only aware of nicotine’s
effect on the body, but designed their products “to enhance those effects and
uses.”142

135. David A. Kessler et al., The Food and Drug Administration’s Regulation of Tobacco Products,
335 NEW ENG. J. MED. 988, 988 (1996).
136. DAVID KESSLER, A QUESTION OF INTENT: A GREAT AMERICAN BATTLE WITH A DEADLY
INDUSTRY 50–51, 87 (2001) (describing citizen petitions that demanded the FDA begin classifying lowtar cigarettes as a drug).
137. Kessler et al., supra note 135.
138. Id.
139. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 321(g)(1)(C) (2012).
140. Kessler et al., supra note 135, at 991.
141. Brief for Petitioner, FDA v. Brown & Williamson Tobacco Corp., 529 U.S. 120 (2000) (No. 981152) (citing FDA Jurisdictional Determination 61 Fed Reg 44,630).
142. Mitch Zeller, 20 Years Later: Returning to FDA to Regulate Tobacco, FDA (Dec. 11, 2013),
https://blogs.fda.gov/fdavoice/index.php/2013/12/20-years-later-returning-to-fda-to-regulate-tobacco/
(describing how Mitch Zeller investigated the tobacco industry from 1994-1996 and career at the Center
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The agency’s findings conclusively established that nicotine is a drug
within FDA regulatory authority, but the question quickly became how to most
appropriately utilize this authority.143 At the time, 1 in 4 American adults were
daily cigarette smokers, and millions more used smokeless tobacco.144 Given the
sheer size of the adult population regularly using tobacco products and addicted
to nicotine, and that 80 % of daily smokers began smoking before the age of 18,
FDA chose to focus on preventing youth from initiating tobacco use.145
On August 11, 1995, the proposed rule entitled “Regulations Restricting the
Sale and Distribution of Cigarettes and Smokeless Tobacco Products to Protect
Children and Adolescents” was published in the Federal Register.146 The
proposed rule focused heavily on restricting youth access to cigarettes and
smokeless tobacco, and limiting the advertising and marketing of these products
to children.147 The rule prohibited the sale of cigarettes and smokeless tobacco
to individuals under the age of 18; required retailers to verify a purchaser’s age
by photographic identification; prohibited free product samples and vending
machines, except in adult-only facilities; limited outdoor advertising, advertising
in publications with significant youth readership, and advertising near schools
and playgrounds; prohibited the sale or distribution of brand-identified
promotional nontobacco items such as hats and tee shirts; and required
manufacturers to provide intended use information on all cigarette and smokeless
tobacco product labels and in cigarette advertising.148
C. Litigation Following FDCA “Drug” and “Device” Regulation
The proposed rule generated the most responses in FDA history, with more
than 700,000 submissions during the public comment period, representing the
views of more than 1 million individuals and entities.149 Major tobacco
manufacturers were among the organizations that submitted detailed comments
of Tobacco Products); Brief for Petitioner at 4–5, FDA v. Brown & Williamson Tobacco Corp., 529 U.S.
120 (200) (No. 98-1152) (citing FDA Jurisdictional Determination 61 Fed Reg 44,635–36, 44,701,
44,849–50) (explaining the evidence that caused FDA to assert jurisdiction over tobacco).
143. Kessler et al., supra note 135, at 191.
144. Cigarette Smoking Among Adults—United States, 1995, 46 MORBIDITY & MORTALITY WKLY.
REP. 1217 (1997), http://www.cdc.gov/mmwr/preview/mmwrhtml/00050525.htm; see also Elizabeth A.
Mumford et al., Smokeless tobacco use 1992–2002: trends and measurement in the Current Population
Survey-Tobacco Use Supplements, 15 TOBACCO CONTROL 166, 168 (2006).
145. Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco Products
to Protect Children and Adolescents, 61 Fed. Reg. 44,396, 44,398 (Aug. 18, 1996) (to be codified at 21
C.F.R. 801).
146. Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco Products
to Protect Children and Adolescents, 60 Fed. Reg. 41,314 (Aug. 11, 1995) (elucidating the proposed rule).
147. See id. at 41,314 (explaining the proposed rule’s intent to restrict access to and advertising of
cigarettes and smokeless tobacco products).
148. Id.
149. Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect
Children and Adolescents, 61 Fed. Reg. 44,396, 44,418 (Aug. 28, 1996) (to be codified at 21 C.F.R. pt.
801).
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to FDA.150 They also filed a joint lawsuit against FDA to enjoin the agency from
promulgating a final rule regulating cigarettes and smokeless tobacco products
less than one month after the rule was announced.151 Brown & Williamson,
Lorillard, Phillip Morris, R.J. Reynolds, and others, argued (1) FDA lacks
jurisdictions to regulate cigarettes and smokeless tobacco, and (2) the advertising
and marketing restrictions included in the proposed rule violate their First
Amendment rights.152
FDA succeeded, in part, in District Court, successfully arguing that the
FDCA authorizes the agency to regulate tobacco products as “drugs” or
“devices.”153 The Court found this authority is limited, however, to regulating
the sale and distribution of tobacco products, and does not include advertising
and marketing restrictions.154 In its decision, the District Court held that (1)
Congress had not withheld jurisdiction to regulate tobacco products from FDA;
(2) the agency may regulate tobacco products pursuant to its FDCA authority;
(3) labeling restrictions and restrictions on youth access were authorized by the
FDCA; and (4) restrictions on the advertisement and promotion of tobacco
products were outside the scope of the FDCA.155 The decision was immediately
appealed to the U.S. Court of Appeals for the Fourth Circuit.156
In Brown & Williamson Tobacco Corp. v. Food & Drug Administration,
the Court of Appeals rejected FDA’s assertion of jurisdiction over tobacco
products as customarily marketed (e.g., absent medical or therapeutic claims).157
The Court of Appeals reversed the District Court decision, finding that tobacco
products were neither a “drug” nor “device” within the FDCA and that Congress
did not intend to include customarily marketed tobacco products within FDA’s
jurisdiction.158 In support of its opinion, the Court cited FDA’s longstanding
position that tobacco products were outside the scope of the FDCA, and that
reading tobacco products into the statute “might well” lead to a ban.159 The
FDCA requires that new devices be proven safe or effective prior to distribution
or sale in the United States, and if there is a reasonable likelihood a device may
cause injury, illness, or death, FDA must issue an immediate cease-distribution

150. Id.
151. Liza Goitein et al., Developments in Policy: The FDA’s Tobacco Regulations, 15 YALE L. &
POL’Y REV. 399, 404 (1996).
152. Id. at 399.
153. Coyne Beahm, Inc. v. U.S. Food & Drug Admin., 966 F. Supp. 1374, 1380 (M.D.N.C. 1997)
(holding that cigarettes are classified as a “drug” or “device” and therefore available for regulation).
154. Id. at 1398–1400.
155. Id. at 1377, 1379, 1388, 1400.
156. Brown & Williamson Tobacco Corp. v. FDA, 153 F.3d 155, 160 (4th Cir. 1998) (reversing the
district court and holding that FDA lacked proper jurisdiction to regulate tobacco products), aff’d, 529
U.S. 120, S. Ct. 1291 (U.S. 2000).
157. Id. at 161, 176.
158. Id. at 162.
159. Id. at 170, 172.
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order.160 Since FDA concluded tobacco products were “dangerous,” “unsafe,”
and kill more than 400,000 American each year, the Court concluded that the
FDCA would require the agency to ban tobacco products, contrary to
Congressional intent.161
In assessing Congressional intent, the Court reviewed decades of proposed
and enacted tobacco legislation.162 The main conclusions were Congress (1)
repeatedly decided against granting FDA authority over tobacco products, and
(2) reserved for itself regulatory authority over tobacco products.163 First,
Congress considered more than a dozen bills between 1956 and 1989 that would
have granted FDA authority over tobacco products.164 Each bill failed, indicating
that Congress was aware FDA lacked jurisdiction and did not want the agency
regulating tobacco products. Second, Congress did enact several statutes directly
regulating the advertising, marketing, packaging and sale of tobacco products.
Passage of FCLAA, CSTHEA, and other legislation demonstrated clear intent
not to delegate regulatory authority to FDA.165 With this information the Court
reversed the holding of the District Court and concluded that FDA lacked the
authority to regulate tobacco products under the FDCA.166 FDA sought certiorari
in the Supreme Court.167
D. FDA v. Brown & Williamson
The Supreme Court granted certiorari and in a 5-4 split affirmed the Court
of Appeals’ decision that FDA lacked jurisdiction to regulate tobacco products
as customarily marketed under the FDCA.168 Delivering the opinion for the
Court, Justice O’Connor used much the same logic as the lower court: (1)
tobacco products do not “fit” the FDCA because the statute requires FDA to ban
dangerous drugs or devices, and (2) Congress did not delegate its authority to
regulate
tobacco
products.169
The Court held that tobacco products did not “fit” the objective and scope

160. 21 U.S.C. § 360e (2012) (requiring FDA to consider the safety and effectiveness of a device when
considering it for premarket approval); 21 U.S.C. § 360h(e)(1)(A) (2012) (authorizing FDA to recall
devices that would cause serious adverse health consequences or death when used as intended).
161. Brown & Williamson Tobacco Corp., 153 F.3d at 163, 166, aff’d, FDA. v. Brown & Williamson
Tobacco Corp., 529 U.S. 120 (2000).
162. Id. at 171–75.
163. Id. at 175–76.
164. Id. at 175 & n.26.
165. See id. at 172–75 (explaining that Congress’s enactment of FCLAA, CSTHEA, and other
legislation “cannot be harmonized with FDA’s assertion of jurisdiction over tobacco products”).
166. Id. at 176.
167. See generally Petition for a Writ of Certiorari, FDA v. Brown & Williamson Tobacco Corp., 529
U.S. 120 (2000) (No. 98-1152).
168. See Brown & Williamson Tobacco Corp., 529 U.S. at 131, 161 (O’Connor, J. majority).
169. See id. at 143, 160–61.
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of the FDCA, because the FDCA was enacted to ensure that all drugs and devices
subject to its provisions are safe for their intended use.170 This requires a
balancing test where FDA determines whether the therapeutic benefits of a drug
or device outweigh the potential health risks to the consumer.171 According to
the Court, conducting such an analysis with tobacco products would be
impossible.172 As FDA’s exhaustive investigation demonstrated, tobacco
products are “unsafe, dangerous, and cause great pain and suffering from
illness.”173 Thus, designating tobacco products as “devices” under the FDCA
would require the agency to ban their distribution and sale. Since Congress
refused to ban tobacco products, instead choosing to regulate their advertising
and promotion, agency regulation would “plainly contradict congressional
intent,” and therefore fall outside the scope of the FDCA.174
Congress’ history of tobacco-specific legislation further demonstrated to
the Court that FDA lacked jurisdiction to regulate tobacco products under the
FDCA.175 Between 1965 and 1992 Congress enacted six separate statutes
regulating tobacco in the interests of public health.176 None of these statutes
granted FDA authority over tobacco products or banned their sale.177 To the
Court majority, this legislative history “effectively ratified” FDA’s longstanding
position that tobacco products were not subject to the FDCA and proved
Congress did not delegate its tobacco authority to the agency.178
In a blistering dissent, Justice Breyer (joined by Justices Stevens, Souter,
and Ginsburg), argued that under a plain language reading of the FDCA, nicotine
is a “drug” and tobacco products are a “device.”179 Moreover, the FDCA’s
primary objective is to protect the public’s health; a goal that is best served by
including tobacco products within the scope of the Act.180 Justice Breyer also
took issue with the Court’s reading of the FDCA as requiring FDA to ban tobacco
products.181 Instead arguing that the statute permitted the agency to choose
alternative remedies more consistent with previous Congressional action.182
Finally, the dissent constructs a statutory and policy argument that scientific
170. Id. at 142.
171. Id. at 141.
172. See id. (explaining that this would require an implausible inquiry into whether tobacco products
purported benefits outweigh the risks to from their use).
173. Id. at 134.
174. Brown, 529 U.S. 161.
175. Id. at 156.
176. Id. at 143.
177. Id. at 144.
178. Id. at 156.
179. Id. at 164, 168–169 (Breyer, J., dissenting).
180. Brown, 529 U.S. 162 (Breyer, J., dissenting).
181. Id. at 174 (Breyer, J., dissenting) (describing the “perverse” consequence of a statute that does
not allow FDA to weigh the consequences of a cigarette ban with the consequences of regulating
cigarettes).
182. Id. at 163 (Breyer, J., dissenting).
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advancements, such as discovering the addictive qualities of nicotine, should
permit FDA to change agency policy related to previously unregulated products
such as cigarettes and smokeless tobacco.183
E. Decade-Long Legislative Battle Ensues
The Supreme Court’s decision invalidated FDA’s final rule regulating
cigarettes and smokeless tobacco, which had been promulgated in August
1996.184 It also ensured that any future regulatory efforts would necessarily have
to be the product of Congress.185 The issue of FDA authority over tobacco
products lay dormant in the courts until 2008 when the agency moved to regulate
electronic cigarettes as drug delivery devices and block their importation into the
United States.186
In the aftermath of the Brown & Williamson decision several bills were
introduced authorizing FDA to regulate tobacco products. During the 107th
Congress (2001-2003) alone seven different bills were filed granting FDA new
regulatory authority over tobacco products. Four bills (S. 190187, S. 2626188, S.
2764189, and H.R. 2180190) would have created a new chapter within the FDCA
solely regulating tobacco products, and three bills (S. 247191, H.R. 1044192, and
H.R. 1097193) would have expanded the drug-delivery device authority to include
tobacco products. None of the introduced bills received a vote, as legislators
continued to work with industry representatives and public health advocates to
craft a bill acceptable to both sides.194
183. Id. at 188–189 (Breyer, J., dissenting).
184. Id. at 127, 161.
185. Id. at 160–61.
186. Smoking Everywhere, Inc. v. FDA, 680 F. Supp. 2d 62, 64 (D.D.C.), aff’d sub nom. Sottera, Inc.
v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010).
187. National Youth Smoking Reduction Act, S. 190, 107th Cong. (2001) (expanding the definition
of tobacco product in the FDCA).
188. Youth Smoking Prevention and Public Health Protection Act, S. 2626, 107th Cong. (2002)
(amending the FDCA to include an expanded definition of “tobacco product”).
189. Tobacco Livelihood and Economic Assistance for Our Farmers Act of 2002, S. 2764, 107th
Cong. (2002) (strengthening provisions respecting adulterated and misbranded tobacco products).
190. National Youth Smoking Reduction Act, H.R. 2180, 107th Cong. (2001) (revises the definition
of “tobacco product” to include any product made or derived from tobacco that is intended for human
consumption).
191. Kids Deserve Freedom from Tobacco Act of 2001, S. 247, 107th Cong. (2001) (amending
language to expand the definition of a “restricted device”).
192. Child Tobacco Use Prevention Act of 2001, H.R. 1044, 107th Cong. (2001) (expanding the
Federal Food, Drug, and Cosmetic Act jurisdiction over tobacco products as drugs or devices).
193. FDA Tobacco Authority Amendments Act, H.R. 1097, 107th Cong. (2001) (including “a tobacco
product” in the definition of the term “device”).
194. National Youth Smoking Reduction Act, S. 190, 107th Cong. (2001), available at
https://www.congress.gov/bill/107th-congress/senatebill/190?q=%7B%22search%22%3A%5B%22Tobacco%22%5D%7D&resultIndex=1 (explaining that S.
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In early 2004, Senators Ted Kennedy (D-MA) and Bill DeWine (R-OH)
and Representatives Tom Davis (R-VA) and Henry Waxman (D-CA) introduced
the “Family Smoking Prevention and Tobacco Control Act” (S. 2461195, H.R.
4433196), a bipartisan bill authorizing FDA to regulate tobacco products and
codifying the 1996 agency regulations.197 The bill was widely endorsed by both
the tobacco industry and public health community.198 Philip Morris and the
Campaign for Tobacco-Free Kids even proclaimed “enthusiastic” support, but
after receiving unanimous consent in the Senate the House failed to take
legislative action.199 Senator Kennedy and Representatives Davis and Waxman
re-introduced the bill in 2005 and 2007, with the 2007 version even passing the
House by a vote of 326-102.200 Strong opposition from the Bush Administration,
the Secretary of Health and Human Services, and the FDA Commissioner,
however, kept the upper house from voting on the bill.201
The 111th Congress (2009-2011) convened on January 3, 2009, and with
the support of administration of the the newly elected President, Barack Obama,
the Family Smoking Prevention and Tobacco Control Act (“Tobacco Control
Act”) was reintroduced.202 The bill passed the House on April 2, 2009, the Senate
190 was read twice and referred to Committee but went no further); Youth Smoking Prevention and Public
Health Protection Act, S. 2626, 107th Cong. (2001), available at https://www.congress.gov/bill/107thcongress/senate-bill/2626 (stating that S. 2626 was read twice and referred to Committee but went no
further); Tobacco Livelihood and Economic Assistance for Our Farmers Act of 2002, S. 2764, 107th
Cong. (2001), available at https://www.congress.gov/bill/107th-congress/senate-bill/2764 (explaining
that S. 2764 was read twice and referred to Committee but went no further); National Youth Smoking
Reduction Act, H.R. 2180, 107th Cong. (2001), available at https://www.congress.gov/bill/107thcongress/house-bill/2180 (stating that H.R. 2180 was referred to Committee and a Subcommittee but went
no further); KIDS Act, S. 247, 107th Cong. (2001), available at https://www.congress.gov/bill/107thcongress/senate-bill/247 (explaining that S. 247 was read twice and referred to Committee but went no
further); Child Tobacco Use Prevention Act of 2001, H.R. 1044, 107th Cong. (2001), available at
https://www.congress.gov/bill/107th-congress/house-bill/1044 (stating that H.R. 1044 was referred to
Committee but went no further); FDA Tobacco Authority Amendments Act, H.R. 1097, 107th Cong.
(2001), available at https://www.congress.gov/bill/107th-congress/house-bill/1097 (stating that H.R.
1097 was referred to Committee and a Subcommittee but went no further); see also C. STEPHEN REDHEAD
& VANESSA K. KURROWS, FDA TOBACCO REGULATION: HISTORY OF THE 1996 RULE AND RELATED
LEGISLATIVE ACTIVITY, 1998-2008 2, FN2 (Cong. Res. Serv. ed., 2009) (explaining while no bills
received a vote in the 107th Congress, lawmakers worked for months in negotiations balancing “the
competing interests of public health groups and the tobacco industry”).
195. Family Smoking Prevention and Tobacco Control Act, S. 2461, 108th Cong. (2004).
196. Family Smoking Prevention and Tobacco Control Act, H. R. 4433, 108th Cong. (2004).
197. REDHEAD & KURROWS, supra note 194, at 1–2.
198. Id. at 13.
199. Id.
200. Id. at 1–2.
201. REDHEAD & BURROWS, supra note 194, at 14 (stating that the Bush Administration, along with
the FDA Commissioner and Secretary of HHS, were concerned that the bill would give the impression
that the regulated tobacco products were safe, which would ultimately encourage individuals to smoke).
202. Family Smoking Prevention and Tobacco Control Act, H.R. 1256, 111th Cong. (2009); Statement
of Administration Policy: H.R. 1256 – Family Smoking Prevention and Tobacco Control Act, THE
AMERICAN PRESIDENCY PROJECT (Apr. 1, 2009), http://www.presidency.ucsb.edu/ws/?pid=85939
(expressing the support of the Obama administration for H.R. 1256); Judy Schneider et al., The First Day
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on June 11, 2009, and was signed by the President on June 22, 2009.203 After
nearly 15 years, FDA was granted the authority over the tobacco products that
the agency had asserted in its proposed 1995 rule.
F. The Family Smoking Prevention and Tobacco Control Act
The Tobacco Control Act gives FDA authority to regulate the manufacture,
distribution, and marketing of tobacco products, including specific restrictions
on the marketing of tobacco products to youth.204 The Act also requires FDA to
reissue the 1996 regulations that were struck down in Brown & Williamson,
including: minimum packaging requirements for cigarettes, minimum purchase
age and ID requirements, and bans on free product samples, self-service displays,
and tobacco-brand sponsorship of sporting and entertainment events.205 In
addition, the Act prohibits the sale of flavored cigarettes and the use of modified
risk terms such as “light,” “mild,” and “low tar.”206
The Act defines “tobacco product” as “any product made or derived from
tobacco that is intended for human consumption.”207 While this broad definition
encompasses all tobacco products, the Act provides specific requirements and
restrictions applicable only to cigarettes, smokeless tobacco, and roll-your-own
tobacco.208 Congress gave FDA the power to regulate all tobacco products (e.g.,
cigars, hookah, and ENDS), but requires the agency to first promulgate a
regulation specifically asserting that power over any tobacco products other than
cigarettes, smokeless tobacco, and roll-your-own tobacco.209
Most importantly, with few exceptions, the Tobacco Control Act expressly
permits state and local governments to enact more stringent measures.210
Previous federal tobacco legislation largely preempted state and local regulatory
efforts.211 In Lorillard Tobacco Co. v. Reilly (2001), the Supreme Court held
of the New Congress: A Guide to Proceedings on the House Floor, CONG. RES. SERV., 1 (2010)
(explaining that the 111th congress convened on January 6, 2009).
203. Family Smoking Prevention and Tobacco Control Act, H.R. 1256, 111th Cong. (2009), available
at https://www.congress.gov/bill/111th-congress/house-bill/1256.
204. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776, 1830
(2009) (codified at 21 U.S.C. § 301–387).
205. See id. at 1830.
206. See id. at 1799, 1812.
207. Id. at 1783.
208. See, e.g., id. at 1830−32 (prohibiting the distribution of free samples of cigarettes, smokeless
tobacco, and other tobacco products).
209. See id. at 1786.
210. See id. at 1823 (stating that local and state governments may enact more stringent requirements
than established by this chapter).
211. See Federal Cigarette Labeling and Advertising Act, Pub. L. No. 89-92, 79 Stat. 282, 283 (1965)
(preempting state laws that would require cigarette manufacturers to print a notice on their packaging that
indicates the health consequences of smoking); see also Public Health Cigarette Smoking Act of 1969,
Pub. L. No. 91-222, 84 Stat. 84, 88 (1970) (preempting requirement or prohibition based on smoking and
health imposed by the state with respect to advertising or promotion of any cigarettes packages); see also
Comprehensive Smoking Education Act, Pub. L. No. 98-474, 98 Stat. 2200 (1984) (prohibiting state
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that the Federal Cigarette Labeling and Advertising Act (“FCLAA”) preempted
the Attorney General of Massachusetts from promulgating regulations banning
cigarette advertising and sales within 1,000 feet of playgrounds and schools and
limiting point-of-sale advertising.212 Likewise, the U.S. Court of Appeals for the
Second Circuit held FCLAA preempted a New York City Board of Health
regulation requiring tobacco retailers to post graphic warning signs about the
adverse health effects of smoking.213 In contrast, the Tobacco Control Act
preserves the authority of state and local governments to regulate the advertising,
distribution, and sale of tobacco products:
Nothing in this chapter, or rules promulgated under this chapter, shall be
construed to limit the authority of. . .a State or political subdivision of a
State. . .to enact, adopt, promulgate, and enforce any law, rule, regulation, or
other measure with respect to tobacco products that is in addition to, or more
stringent than, requirements established under this chapter, including a law, rule,
regulation, or other measure relating to or prohibiting the sale, distribution,
possession, exposure to, access to, advertising and promotion of, or use of
tobacco products by individuals of any age, information reporting to the State, or
measures relating to fire safety standards for tobacco products. No provision of
this chapter shall limit or otherwise affect any State, tribal, or local taxation of
tobacco
products.214
The Act permits state and local governments to enact more stringent
requirements in areas as disparate as sales and distribution, youth possession, use
(e.g. smoke-free laws), fire safety standards, and excise taxes.215 State and local
governments may even regulate the time, place, and manner of tobacco
advertising and marketing within the boundaries of First Amendment
commercial speech protections.216 Federal law still preempts, however, any
requirement or prohibition related to product manufacturing, including
premarket review, adulteration, misbranding, labeling, and product registration,
as well as the content of tobacco advertisements with respect to health
regulations that concern cigarette and smokeless tobacco advertisements and packaging); see also
Comprehensive Smokeless Tobacco Health Education Act, Pub. L. No. 99-252, 100 Stat. 30, 34 (1986)
(prohibiting federal agencies, state or local statutes or regulations requiring statements relating to the use
of smokeless tobacco products and health).
212. Lorillard Tobacco Co. v. Reilly, 533 U.S. 525, 565–66, 569–71 (2001). The Court also found that
the advertising restrictions as applied to smokeless tobacco and cigars, which were not included in
FCLAA, violated the First Amendment. The Court did allow the ban on self-service displays to remain in
effect, finding this to be a sales practice and not the promotion or advertising of cigarettes. Id. at 569–70
(finding that the advertising restriction applied to smokeless tobacco and cigars and upholding ban on selfservice displays because it was a sales practice and not advertising or promotion).
213. 23-34 94th St. Grocery Corp. v. N.Y.C. Bd. of Health, 685 F.3d 174, 185–186 (2nd Cir. 2012).
214. Family Smoking Prevention and Tobacco Control Act, Pub. L. 111-31, 123 Stat. 1776, 1823
(2009) (codified as 21 U.S.C. §387p(a)(1)).
215. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, § 101(b)(3), 123 Stat.
1823 (2009) (codified at 21 U.S.C. § 387p(a)(1) (2012)).
216. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, § 203, 123 Stat. 1846
(2009) (codified at 15 U.S.C. §1334(c) (2012)).
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warnings.217 This preemption reflects that tobacco products manufactured in one
state are generally available for sale across the country such that state-by-state
product standards could cripple the industry in seeming violation of the spirit of
the Commerce Clause.218
G. New Kids on the Block
In 2007, ENDS manufacturers Smoking Everywhere and NJOY began
importing inventory into the United States and marketing their products for
“smoking pleasure.”219 Although designed to resemble traditional cigarettes,
these cig-alike products do not burn or contain tobacco.220 In fact, NJOY’s
promotional materials emphasized “it’s NOT a real cigarette, there is NO real
smoke, flame, tar, or tobacco,” and promised to “deliver the nicotine hit that
smokers crave.”221 In October 2008, FDA denied entry to a shipment of Smoking
Everywhere products from China because they appeared to be an “unapproved
drug-device combination product.”222 Shortly thereafter, FDA denied entry to a
shipment of NJOY products on the same grounds.223 In response, Smoking
Everywhere filed suit in the U.S. District Court for the District of Columbia, and
NJOY joined as an intervenor-plaintiff.224 The ENDS manufacturers sought a
preliminary injunction barring FDA from regulating their products under the
drug/device provisions of the FDCA.225 They argued that Brown & Williamson
applies equally to electronic cigarettes as to conventional cigarettes because the
nicotine in electronic cigarettes is derived from tobacco, and that FDA lacks
authority under the FDCA to regulate their products as customarily marketed.226
FDA countered that the Supreme Court decision did not extend to electronic
cigarettes, which do not contain tobacco and are not subject to the federal statutes
217. See Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, § 101(b)(3), 123
Stat. 1823 (2009) (codified as amended in 21 U.S.C. § 378p(a)(2)(A) (2012)) (stating that federal law
preempts state regulation relating to product manufacturing, including premarket review, adulteration,
misbranding, labeling and product registration); see also 15 U.S.C. § 1334(b) (stating that federal law
preempts state regulations pertaining to health-related warning labels); see generally Fact Sheet 3:
Preemption of State and Local Authority, TOBACCO CONTROL LEGAL CONSORTIUM 1–2 (July 2009),
http://publichealthlawcenter.org/sites/default/files/fda-3.pdf (providing an overview of recent changes to
preemption of tobacco regulations).
218. Family Smoking Prevention and Tobacco Control Act § 2(9)–(12).
219. Smoking Everywhere, Inc. v. U.S. Food & Drug Admin., 680 F.Supp.2d 62, 64 (D.D.C. 2010),
aff’d sub nom. Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010).
220. Id. at 63–64.
221. Brief for Appellants at 3, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010)
(No. 10-5032).
222. See Smoking Everywhere, Inc., 680 F.Supp.2d at 64–65; see also Brief for Appellants at 4,
Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010) (No. 10-5032).
223. See Smoking Everywhere, Inc., 680 F.Supp.2d at 65–66.
224. Id. at 64–65.
225. Id. at 63.
226. Id. at 66–67.
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the Brown & Williamson Court relied upon in finding that Congress has not
intended to give regulatory power over tobacco products to FDA.227 The
injunction was granted by the District Court and FDA appealed.228
Similar to FDA’s attempt to regulate tobacco products in 1996, the agency
invoked its FDCA authority to regulate drugs and drug-delivery devices when
preventing the importation of ENDS.229 However, the issue of whether the
agency has authority to regulate ENDS under the drug/device provisions of the
FDCA soon became entangled with the issue of whether the Tobacco Control
Act, signed into law on June 22, 2009, provided the agency with authority to
regulate ENDS.230 Therefore, as the case moved to the U.S. Court of Appeals for
the District of Columbia Circuit, the question was not only whether FDA could
regulate electronic cigarettes, but whether Congress had authorized the agency
to regulate electronic cigarettes under the drug-device provisions of the FDCA
or
under
the
Tobacco
Control
Act.231
FDA moved forward in Sottera v. Food and Drug Admin. with three main
arguments: (1) electronic cigarettes are combination drug devices under the
provisions of the FDCA, (2) the reasoning of Brown & Williamson does not
apply to electronic cigarettes, and (3) the Tobacco Control Act does not restrict
FDA’s preexisting authority under the FDCA to regulate electronic cigarettes as
drug-delivery devices.232 First, FDA argued that unlike traditional cigarettes, the
agency had regulated nicotine products under the FDCA, without challenge, for
at least two decades.233 For instance, the agency regulated “Favor Smokeless
Cigarettes,” a product virtually identical to ENDS, under its FDCA authority
beginning in the mid-1980s.234 FDA advised Favor that the product was “a
nicotine delivery system intended to satisfy a nicotine dependence and to affect
the structure and one or more functions of the body” and therefore an unapproved
new drug.235 FDA likewise had long used its drug-device authority to regulate
nicotine hand gels, lollipops, lip balms, and water.236 All of these similar
products were regulated as drug-devices under the FDCA, and FDA argued that
the electronic cigarettes sold by NJOY and Smoking Everywhere were likewise
subject
to
the
Act’s
provisions.237

227. Id. at 67–68.
228. Id. at 66; Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010).
229. Sottera, 627 F.3d at 894-95.
230. See id. at 892, 894.
231. See id. at 892.
232. See id. at 895.
233. Id. at 902 (Garland, J., concurring).
234. Id.
235. Brief for Appellant at 14–15, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir.
2010). (No. 10-5032).
236. Smoking Everywhere, Inc., 680 F. Supp. 2d at 79 n.13.
237. Brief for Appellant at 9, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010).
(No. 10-5032).
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Second, the Brown & Williamson Court gleaned from a handful of federal
statutes that Congress had reserved tobacco authority for itself and did not intend
for FDA to regulate cigarettes.238 In Sottera, FDA argued that Brown &
Williamson did not apply to electronic cigarettes because, unlike conventional
cigarettes, electronic cigarettes were not subject to any of the federal statutes
cited in the Supreme Court case as Congress’s intent to preclude FDA oversight
in the area of tobacco control.239 Rather, electronic cigarettes were never
mentioned in Brown & Williamson, nor were they ever the subject of specific
federal
legislation.240
Third, FDA argued that the newly enacted Tobacco Control Act did not
limit its ability to regulate electronic cigarettes or other drug-device products
under the FDCA.241 While the Tobacco Control Act granted FDA new authority
over any product derived from tobacco, the statute expressly excluded any drug,
device or combination product regulated under the FDCA.242 According to FDA,
since electronic cigarettes “fit” the drug-device statutory definition FDA was
authorized to regulate these products under its preexisting FDCA authority.243
NJOY opposed FDA’s action on nearly identical grounds as the cigarette
manufacturers in Brown & Williamson.244 The company argued that (1)
electronic cigarettes are tobacco products and (2) the FDCA does not grant FDA
authority to regulate tobacco products absent therapeutic claims (i.e. as
customarily marketed).245 First, the Tobacco Control Act defines “tobacco
product” as “any product made or derived from tobacco,” which even FDA
conceded encompasses electronic cigarettes like those sold by NJOY that contain
nicotine derived from tobacco.246 Second, NJOY asserted that in passing the
Tobacco Control Act Congress ratified the Brown & Williamson decision that
FDA lacked jurisdiction over tobacco products under the FDCA.247 Given that
Congress enacted specific legislation to regulate “any product made or derived

238. Food & Drug Admin. v. Brown & Williamson Tobacco Corp., 529 U.S. 120, 143, 156 (U.S.
2000).
239. Sottera, Inc., 627 F.3d at 895.
240. Brief of Appellant at 14, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010)
(No. 10-5032).
241. Id. at 19–20.
242. 21 U.S.C. § 321 (rr)(2) (2012).
243. Brief for Appellants at 19–20, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (No. 10-5032).
244. Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891, 893 (D.C. Cir. 2010).
245. Brief for Appellee at 25, 38, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010)
(No. 10-5032).
246. 21 U.S.C. § 321 (rr)(1) (2016) (providing a broad definition of “tobacco product” to extend the
FDA’s regulatory authority to any product made or derived from tobacco); Brief for Appellee at 2-3,
Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010) (No. 10-5032) (explaining that the
FDA conceded that e-cigarettes qualify under the statutory definition of “tobacco products” because they
deliver nicotine “made or derived from tobacco”).
247. Brief for Appellee at 46, Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (D.C. Cir. 2010)
(No. 10-5032).
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from tobacco,” the company argued that their products, which are derived from
tobacco, could only be regulated under the Tobacco Control Act.248
In its decision the Court of Appeals admitted that Brown & Williamson was
not “crystal clear,” but ultimately sided with NJOY holding that electronic
cigarettes fit into the definition of “tobacco product” under the Tobacco Control
Act and Congress did not intend for tobacco products to be regulated as
drug/devices absent a therapeutic claim.249 Rather than appeal the decision, FDA
elected to regulate NJOY and other ENDS products under its tobacco control
authority through the “deeming rule” process outlined in the Tobacco Control
Act.250
VII. THE “DEEMING RULE”
The Tobacco Control Act grants FDA immediate authority to regulate
cigarettes, cigarette tobacco, smokeless tobacco, and roll-your-own tobacco, and
contains specific prohibitions on the advertising and sale of these products.251
The Act does not expressly regulate other tobacco products such as cigars, pipe
tobacco, hookah, or ENDS, but FDA may promulgate regulations governing any
product derived from tobacco.252 In order to extend agency oversight to include
other tobacco products such as ENDS, FDA must first issue regulations
“deeming” the product as subject to its tobacco regulatory authority.253 Once
deemed, the agency may regulate the manufacturing, distribution, marketing, and
sale of any tobacco product.254
On April 25, 2014, nearly five years after the Tobacco Control Act was
enacted, FDA published the proposed Deeming Rule in the Federal Register.255
248. Id. at 2, 24–5.
249. Sottera, Inc., 627 F.3d at 891, 893 (finding Brown & Williamson not “crystal clear” because the
case focused on the FDA’s authority under the drug/device provisions of the FDCA, rather than on the
particular products that the statute covers).
250. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as
Amended by the Family Smoking Prevention and Tobacco Control Act, 79 Fed. Reg. 23,142 (Apr. 25,
2104), available at https://www.gpo.gov/fdsys/pkg/FR-2014-04-25/pdf/2014-09491.pdf (explaining the
decision not to appeal Sottera and instead extend its control to other types of tobacco products that meet
the statutory definition of “tobacco product”); Family Smoking Prevention and Tobacco Control Act, Pub.
L. No. 111-31, § 901(b), 123 Stat. 1776 (2009) (codified at 21 U.S.C. 387a(b)) (“This chapter shall apply
to all… other tobacco products that the Secretary by regulation deems to be subject to this chapter.”).
251. Id. (indicating that all the prohibitions outlined in the act apply immediately to “cigarettes,
cigarette tobacco, roll-your-own tobacco, and smokeless tobacco”).
252. Id.
253. Id.
254. Family Smoking Prevention and Tobacco Control Act, § 901(b), 906(d) Pub. L. No. 111-31, 123
Stat. 1776 (2009) (codified at 21 U.S.C. 387a(b)) (2012) (applying all the regulations in the act regarding
manufacturing, distribution, marketing and sale to tobacco products deemed within their jurisdiction by
regulation).
255. Deeming Tobacco Products to Be Subject to the Federal Food, Drug, and Cosmetic Act;
Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for
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The proposed rule extended agency jurisdiction to all other present and future
products derived from tobacco, specifically including ENDS, cigars, pipe
tobacco, nicotine gels, waterpipe/hookah tobacco, and dissolvable tobacco
products.256 More than 135,000 comments were filed in response to the draft
rule.257 FDA reviewed each submission, as required by statute, prior to
submitting the final rule to the White House Office of Management and Budget
(OMB) for approval.258 OMB approval resulted in the removal of several
proposed regulations including the banning of flavors and premarket approval
for ENDS.259 The final rule was published more than two years later, on May
10, 2016, with an effective date of August 8, 2016,260 although many provisions
governing
ENDS
manufacturers
have
later
effective
dates.261
The Deeming Rule is a foundational rule that authorizes FDA to regulate
all products derived from tobacco.262 The rule also triggers specific requirements
and restrictions for tobacco manufacturers and retailers.263 All newly deemed
tobacco product manufacturers must register with the FDA and report product
and ingredient listings; only market new products after FDA review; not make
reduced risk claims without scientific data and FDA approval; not distribute free
samples; and pay user fees.264 In addition, retailers may not sell tobacco products
to individuals under 18 years of age and must check ID for anyone appearing to

Tobacco Products, 79 Fed. Reg. 23,142, 23,148 (Apr. 25, 2014) (codified at 21 C.F.R. pts. 1100, 1140,
1143).
256. Id. at 23,143.
257. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act;
Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for
Tobacco Products, 81 Fed. Reg. 28,974, 28,982 (May 10, 2016) (codified at 21 C.F.R. pts. 1100, 1140,
1143), available at https://www.gpo.gov/fdsys/pkg/FR-2016-05-10/pdf/2016-10685.pdf.
258. See 5 U.S.C. § 553 (2012) (requiring administrative agencies to consider relevant comments);
see
also
FDA
Rules
and
Regulations,
U.S.
FDA,
https://www.fda.gov/RegulatoryInformation/RulesRegulations/ (last visited Mar. 10, 2017) (explaining
after issuing a proposed rule, it reviews the comments and if the proposed or final rule is “significant” the
OMB must review it).
259. Desmond Jenson & Joelle Lester, FDA Overruled By White House On Removing Flavored Cigars
and E-Cigarette Liquids From The Market, PUB. HEALTH L. CTR. (June 2, 2016),
http://publichealthlawcenter.org/blogs/2016-06-02/fda-overruled-white-house-removing-flavoredcigars-and-e-cigarette-liquids-market.
260. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act;
Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for
Tobacco Products, 81 Fed. Reg. 28,974 (May 10, 2016) (codified at 21 C.F.R. pts. 1100, 1140, 1143).
261. Id. at 29,003.
262. Id. at 28,982, 29,003.
263. Id. at 29,057.
264. Deeming Tobacco Products to Be Subject to the Federal Food, Drug, and Cosmetic Act;
Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for
Tobacco Products, 79 Fed. Reg. 23,142, 23,148 (Apr. 25, 2014) (codified at 21 C.F.R. pts. 1100, 1140,
1143).
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be under 27 years of age; vending machine sales are prohibited except in adultonly facilities.265
In the Deeming Rule, FDA also clarified that all ENDS products are subject
to the Tobacco Control Act and that most provisions regulating cigarettes,
smokeless tobacco, and roll-your-own tobacco will extend to these products,
including premarket approval.266 Under the Act, manufacturers of new tobacco
products must secure FDA authorization prior to marketing their product.267 The
agency will consider several factors in determining whether a product is new and
therefore subject to the premarket approval process, but the most important is
whether a “substantially equivalent” tobacco product was commercially
available on or before February 15, 2007.268 This issue is critical for ENDS
manufacturers because there is uncertainty as to whether any electronic devices
containing liquid nicotine were on the U.S. market by this date.269 Without a
substantially equivalent product, ENDS manufacturers must undergo the
lengthy, costly, and uncertain premarket tobacco application process.270
As discussed earlier, Favor Smokeless Cigarettes – electronic smoking
devices that aerosolized liquid nicotine – were briefly marketed in the mid1980s, but these devices were non-flavored.271 Moreover, while Favor
Smokeless Cigarettes resembled closed-system cig-alikes in size and design,
they are likely not similar enough to the large tank open systems that dominate
the ENDS market today for substantial equivalence. The Deeming Rule permits

265. Deeming Tobacco Products to Be Subject to the Federal Food, Drug, and Cosmetic Act;
Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for
Tobacco Products, 79 Fed. Reg. 23,142, 23,160, 23,162 (Apr. 25, 2014) (codified at 21 C.F.R. pts. 1100,
1140, 1143).
266. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act;
Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for
Tobacco Products, 81 Fed. Reg. 28,974, 28,993, 29,035 (May 10, 2016) (codified at 21 C.F.R. pts. 1100,
1140, 1143).
267. Id. at 28,990, 29,035.
268. Id. at 28,991.
269. See, e.g., Daniela Saitta et al., Achieving Appropriate Regulations for Electronic Cigarettes, 5
THERAPEUTIC ADVANCES CHRONIC DISEASE 50, 61 (2014) (stating that “[p]roducts introduced after that
date would need to prove that they are ‘substantially equivalent’ to products that were on the market on
or before 15 February 2007… [t]he unintended consequence of applying this provision to e-cigarettes
would be to remove from the market products that have undergone significant improvements, freezing the
technology at a stage of development when battery life was too short, vapour production was inconsistent
and cartridges leaked…”).
270. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as
Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and
Distribution of Tobacco Products and Required Warning Statements for Tobacco Products, 81 Fed. Reg.
28,974, 29,079 (May 10, 2016) (codified at 21 C.F.R. pts. 1100, 1140,1143) (providing three marketing
pathways for new tobacco products – substantial equivalence to a valid predicate product, exemption, and
premarket tobacco product application).
271. Reducing the Health Consequences of Smoking: 25 Years of Progress, U.S. DEP’T HEALTH &
HUM. SERVS. (1989), available at https://profiles.nlm.nih.gov/ps/access/NNBBXS.pdf (describing how
FDA determined that the Favor Smokeless Cigarette was a “new drug” under the FDCA).
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ENDS manufacturers to continue marketing their products for up to 3 years if
they submit substantial equivalence or premarket tobacco applications, but
industry experts claim premarket approval would be catastrophic for the ENDS
market.272 Several lawsuits have been filed challenging FDA’s decision to
subject ENDS to the premarket approval process.273 In addition, Congress could
step-in and alter the substantial equivalence date to accommodate ENDS
manufacturers or otherwise exempt the devices from premarket approval.274 The
regulatory landscape post-deeming remains uncertain for ENDS, but the devices
are expected to stay on the market until FDA and the industry determine the
appropriate pathway to regulation.
FDA can and will adopt additional rules in the future regulating the newly
deemed tobacco products, including ENDS.275 These rules could restrict
ingredients or limit concentrations, restrict online sales, ban flavored products or
self-service displays (both of which currently apply to cigarettes), or limit
advertising and promotion.276 The Deeming Rule represents the beginning, not
the end, of ENDS regulation. FDA may enact, and is expected to pursue, a wide
variety of provisions not specified in the Deeming Rule in order to protect public
health.
A. Child Nicotine Poisoning Prevention Act
While the long-term health effects of ENDS use remain uncertain, acute
exposure to liquid nicotine can result in immediate adverse health effects,
particularly in young children. As little as 1 tablespoon of liquid nicotine is
272. Burke, supra note 60 (stating that “if the FDA’s current approach is implemented, producers
would be required to remove every single product from the market and submit expensive and burdensome
applications for the chance to allow their products to stay on the market”).
273. Lydia Wheeler, Lawsuits Mount Against FDA Regs on E-cigarettes, THE HILL (Jul. 10, 2016),
http://thehill.com/regulation/court-battles/287056-lawsuits-mount-against-fda-regs-on-e-cigarettes (“five
lawsuits have been filed against the agency over the rules finalized… which require any product that hit
store shelves after February 2007 to go through a costly approval process).
274. Vaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS), FDA,
http://www.fda.gov/TobaccoProducts/Labeling/ProductsIngredientsComponents/ucm456610.htm (last
visited Mar. 10, 2017).
275. See Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as
Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and
Distribution of Tobacco Products and Required Warning Statements for Tobacco Products, 81 Fed. Reg.
28,974, 28,975 (May 10, 2016) (codified at 21 C.F.R. pts. 1100, 1140,1143) (explaining that the deeming
rule allows them to regulate newly deemed tobacco products appropriately for the protection of public
health and they plan to do so).
276. See Vaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS), supra
note 274 (explaining that FDA now regulates the “manufacture, import, packaging, labeling, advertising,
promotion, sale, and distribution of ENDS”); see also Commonly Asked Questions: About the Center for
Tobacco
Products,
FDA,
http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/AbouttheCenterfo
rTobaccoProducts/ucm378205.htm (last visited Mar. 10, 2017) (explaining that the existing framework
for traditional cigarettes is being extended to newly deemed tobacco products).
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“capable of killing four small children.”277 Even smaller levels of exposure to
liquid nicotine, whether absorbed through the skin or eyes, or ingested, can lead
to nausea, cardiac arrest, seizure, or coma.278 In 2014, poison control centers
received more than 4,000 liquid nicotine exposure calls, and over half were for
young
children.279
To address the rising number of accidental liquid nicotine poisonings,
Congress enacted the Nicotine Poisoning Prevention Act in January 2015.280 The
Act requires any liquid nicotine container sold in the United States to meet the
“special packaging” requirements for hazardous household products.281
Beginning July 26, 2016, all liquid nicotine containers must be significantly
difficult for children under 5 years of age to open, which is the standard for all
hazardous household substances.282 This means 80 % of the children tested are
unable to open the packaging within 10 minutes. The Act also grants the
Consumer Products Safety Commission (CPSC) the power to enforce the new
provisions.283 Finally, the Act does not limit FDA’s authority over ENDS or
liquid nicotine.284 Rather, FDA is permitted to otherwise regulate liquid nicotine,
including adopting more stringent packaging standards.285
VIII. STATE AND LOCAL POLICY RECOMMENDATIONS
Prior to the Tobacco Control Act, tobacco products were primarily
regulated at the state and local level.286 With its passage, FDA stepped to the fore
of tobacco regulation, establishing and administering a comprehensive federal
tobacco control program.287 The agency now regulates the manufacture,
marketing, labeling, distribution, and sale of tobacco products; develops mass
media campaigns to educate the public about the dangers of tobacco products;
277. S. REP. NO. 114-12, at 1–2 (2015).
278. Neal L. Benowitz et al., Prolonged Absorption with Development of Tolerance to Toxic Effects
After Cutaneous Exposure to Nicotine, 42 CLINICAL PHARMACOLOGY & THERAPEUTICS 119, 119–20
(1987).
279. E-Cigarettes
and
Liquid
Nicotine,
AM. ASS’N POISON CONTROL CTRS.,
http://www.aapcc.org/alerts/e-cigarettes/ (last visited Mar. 10, 2017).
280. Child Nicotine Poison Prevention Act of 2015, Pub. L. No. 114-116, 130 Stat. 3 (codified at 15
U.S.C. § 1471 (2016)).
281. Id.
282. Liquid Nicotine Packaging Surveillance Revised Guidance, U.S. CONSUMER SAFETY COMM.
(July 22, 2016), https://www.icphso.org/files/cpsc/cpsc-guidance-liquid-nicotine.pdf (informing the
industry that all liquid nicotine must be sold in “special packaging” as of July 26, 2016); 16 C.F.R. §
1700.1(a) (2016) (defining “special packaging” as packaging that is “significantly difficult for children
under 5… to open”).
283. Child Nicotine Poisoning Prevention Act of 2015, Pub. L. No. 114-116, 130 Stat. 3 (2016)
(codified at 15 U.S.C. §1471).
284. Id.
285. Id.
286. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776 (2009).
287. Id. (adding additional regulations and legislation to tobacco and other drugs in order to assist in
preventing adolescent drug use due to recent failures to prevent wide-spread drug use).
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and funds and directs scientific research to better understand the harms
associated with tobacco use and how to reduce them.288 Through the Deeming
Rule FDA also expanded its jurisdiction to include any product derived from
tobacco, including ENDS.289 But, the Tobacco Control Act and the Deeming
Rule leave significant gaps in regulation.290 Gaps that state and local
governments are expressly authorized by the Tobacco Control Act to fill.291
In 2014, the Surgeon General released The Health Consequences of
Smoking – 50 Years of Progress, a 900-page report highlighting the progress
made to reduce tobacco use in the United States and looking ahead to the
immense burdens still presented by smoking.292 Chapter 14 of the report
identifies the most effective tobacco control measures for decreasing youth
tobacco use: (1) taxation/price increases, (2) restricting indoor use, (3) restricting
youth access, and (4) bans and restrictions on advertising and promotion.293
These measures have been largely credited with reducing youth cigarette
smoking rates from 28 % in 1991 to 9.3 % in 2015.294 Yet, federal laws mostly
do not extend these effective measures to ENDS.295
Cigarettes are subject to a $1.01 per pack federal excise tax, while ENDS
and e-liquid are not subject to any federal taxation.296 The Deeming Rule extends
youth sales and ID check provisions to ENDS, but not the bans on self-service
displays and flavored products.297 Cigarette advertising is heavily regulated, with
bans on television and radio ads, event sponsorship, promotional items, and

288. Mitchell Zeller, Progress and Challenges: The State of Tobacco Use and Regulation in the U.S.,
FOOD & DRUG ADMIN. (May 15, 2014), https://www.fda.gov/NewsEvents/Testimony/ucm397399.htm.
289. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as
Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and
Distribution of Tobacco Products and Required Warning Statements for Tobacco Products, 81 Fed. Reg.
28,974 (May 10, 2016) (to be codified at 21 C.F.R. pts. 1100, 1140, 1143).
290. State and Local Tobacco Regulation in a Post-Deeming World, TOBACCO CONTROL LEGAL
CONSORTIUM, http://publichealthlawcenter.org/sites/default/files/resources/tclc-fda-deemingreg-stateand-local-regulation-2016.pdf (last updated May, 2016) (noting there are gaps for smokeless tobacco,
cigars, e-cigarettes and others in areas like prohibition on self-service displays, minimum package size
requirements, prohibition on characterizing flavors and required notice of advertising in a non-traditional
medium).
291. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776, 1823
(2009).
292. OFFICE OF THE SURGEON GENERAL, U.S. DEP’T OF HEALTH AND HUMAN SERVICES, THE
HEALTH CONSEQUENCES OF SMOKING – 50 YEARS OF PROGRESS (2014).
293. Id. at 788.
294. Cigarette Smoking Among U.S. High School Students at an All-Time low, but E-Cigarette Use a
Concern, CDC (2016), https://www.cdc.gov/media/releases/2016/p0609-yrbs.html.
295. Michael Freiburg, Options for State and Local Governments to Regulate Non-Cigarette Tobacco
Products, 21 ANNALS HEALTH L. 407 (Dec. 2012).
296. Federal Excise Tax Increase and Related Provisions, ALCOHOL & TOBACCO TAX & TRADE
BUREAU, https://www.ttb.gov/main_pages/schip-summary.shtml (last updated Sept. 4, 2012) (listing
tobacco products subject to federal taxes, a list that does not include ENDS or e-liquid products).
297. State and Local Tobacco Regulation in a Post-Deeming World, supra note 290.
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magazines with youth readership.298 In contrast, ENDS may be marketed on any
medium, including TV, radio, magazines, billboards, and the internet.299
As discussed, the Tobacco Control Act preserves the authority of state and
local governments to further regulate ENDS.300 The following are evidencebased policy interventions that communities across the country have
implemented to reduce youth tobacco use. These policies can and should be
extended to ENDS to tackle rising youth use, and a growing number of
jurisdictions have applied many of these provisions to ENDS. In some instances,
these are laws passed to apply specifically to ENDS; in others, jurisdictions are
choosing to incorporate ENDS into laws that already regulate tobacco products
and new provisions regulating tobacco products. The dynamic of including
ENDS in laws regulating tobacco products should expand now that FDA has
deemed ENDS to be tobacco products.301
A. Retail Licensing
Retail tobacco licensing laws require businesses to secure a license prior to
selling tobacco products.302 The license enables the state or local government to
identify tobacco retailers and conduct enforcement checks to ensure compliance
with tobacco regulations.303 Jurisdictions may also use retail licensing to restrict
the density and location of tobacco retailers or suspend or revoke the ability to
sell tobacco products for failure to adhere to tobacco regulations.304
At least 40 states and the District of Columbia require tobacco retailers to
secure a retail tobacco license.305 In contrast, only 14 states and the District of
298. Public Health Cigarette Smoking Act of 1969, Pub. L. No. 91-222 § 6, 84 Stat. 87, 89 (1970)
(making it illegal to advertise cigarettes on any medium of electronic communication subject to the
jurisdiction of the FCC); 21 C.F.R. §§ 1140.32, 1140.34 (2016) (prohibiting cigarette advertisements in
youth magazines, promotional material, and sponsorship of events).
299. Electronic Nicotine Delivery System: Key Facts, CDC OFF. ON SMOKING & HEALTH,
https://www.cdc.gov/tobacco/stateandcommunity/pdfs/ends-key-facts-oct-2016.pdf.
300. Family Smoking Prevention and Tobacco Control Act, Pub. L. 111-31, 123 Stat. 1776, 1823
(2009) (codified as 21 U.S.C. §387p(a)(1)).
301. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, 81 Fed.
Reg. 28974, 29028 (May 10, 2016) (to be codified at 21 C.F.R. pts. 1100, 1140, and 1143). Although FDA
now considers ENDS to be tobacco products by definition, most state and local laws define tobacco
product differently such that the law needs to be amended to include ENDS in any tobacco product
regulation. See Lauren K. Lempert et al., The importance of product definitions in US e-cigarette laws
and
regulations,
TOBACCO
CONTROL,
(2014),
https://tobacco.ucsf.edu/sites/tobacco.ucsf.edu/files/u795/glantz_tobcontrol_ecig_laws%20and%20regs.
2014.pdf (explaining that most state laws define “tobacco product” differently than FDA).
302. Ian McLaughlin, License to Kill?: Tobacco Retailer Licensing as an Effective Enforcement Tool,
TOBACCO
CONTROL
L.
CONSORTIUM,
1,1
(Apr.
2010),
http://publichealthlawcenter.org/sites/default/files/resources/tclc-syn-retailer-2010.pdf.
303. Id. at 2.
304. Id. at 8.
305. See Nationwide Tobacco Retailer License Fees, LEGAL RES. CTR. FOR PUB. HEALTH POL’Y,
https://www.law.umaryland.edu/programs/publichealth/documents/Nationwide_Tobacco_Retailer_Lice
nse_Fees_One_Pager.pdf (last updated May, 2016) (ranking annual tobacco retailer license fees by state).
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Columbia have incorporated ENDS into existing retail tobacco licensing
schemes or enacted ENDS-specific licensing provisions.306 This means that in
36 states, the location, prevalence, and density of ENDS retailers is unknown.307
The rise of vape shops, which generally do not sell traditional tobacco products
and therefore are not required to secure a special trader’s license, further
complicates this issue. Active tobacco compliance check programs are the most
effective measure at reducing youth tobacco access and licensing fees can be
used to support enforcement efforts.308 Without being able to identify the stores
selling ENDS, enforcement entities are incapable of preventing youth access to
tobacco products.
B. Advertising and Promotion Bans
In 2014, more than 18 million middle and high school students (7 in 10)
were exposed to ENDS advertising in retail stores, the internet, magazines and
newspapers, and television and movies.309 ENDS industry advertising
expenditures increased from $6 million to $115 million between 2011 and 2014,
and over this same time youth use more than quadrupled.310 The Tobacco
Control Act authorizes state and local governments to regulate the time, place
and manner of ENDS advertising.311 This means that communities may limit the
location, number, and size of ENDS ads at retail outlets, including prohibiting
ads near cash registers or at youth eye level. Interested communities should be
aware that attempts to regulate ENDS advertising must comply with the First
Amendment, state constitutional law, and the Federal Cigarette Labeling and

306. See U.S. E-Cigarette Regulation: A 50-State Review, TOBACCO CONTROL L. CONSORTIUM, 4, 8,
18, 26–27, 30–32, 34–35, 43, 45, 56, 67, 74–77, 81 (June
15,
2016),
http://publichealthlawcenter.org/sites/default/files/tclc-50state-The-Legal-Landscape-for-ElectronicCigarettes-2016.pdf (listing those states as: Arkansas, California, Indiana, Iowa, Kansas, Louisiana,
Maine, Missouri, Montana, North Carolina, Rhode Island, Utah, Washington and Vermont).
307. Id.
308. See Lindsay F. Stead & Tim Lancaster, A Systematic Review of Interventions for Preventing
Tobacco
Sales
to
Minors
9
TOBACCO
CONTROL
169,
175
(2000),
http://tobaccocontrol.bmj.com/content/tobaccocontrol/9/2/169.full.pdf (explaining that the successful
interventions used a variety of active compliance check strategies including personal visits and mobilizing
community support); see also McLaughlin, supra note 302, at 2 (noting the benefits of self-funding
licensing fee programs).
309. E-Cigarette Ads and Youth, CDC (Jan. 5, 2016), http://www.cdc.gov/vitalsigns/ecigarette-ads/.
310. Id.
311. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776, 1823
(2009) (codified at 21 U.S.C. § 387p (2012)).
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Advertising Act.312 Recent attempts to restrict retail advertising have been met
with legal challenges from the tobacco industry, with mixed results.313
C. Sales Restrictions
Sales restrictions are among the most effective strategies to reduce youth
tobacco use. These restrictions include raising the minimum sales age, restricting
the sale of flavored products, and restricting self-service displays.314 Following
the Deeming Rule federal law sets the minimum age to purchase any tobacco
product at 18 years, but state or local governments may raise the age of access.315
Four states (Alabama, Arkansas, New Jersey, and Utah) set the minimum sales
age at 19, while two others (California and Hawaii) have recently raised it to
21.316 More than 100 localities have joined California and Hawaii in raising the
minimum sales age to 21 including Boston, Chicago, Cleveland, and New
York.317 While primarily targeted at cigarettes, minimum age sales restrictions
generally incorporate ENDS into the law.318 Preliminary studies indicate that
raising the minimum sales age significantly reduces tobacco use by youth age
12-17 years old.319

312. Restricting Tobacco Advertising, TOBACCO CONTROL L. CONSORTIUM, 3–4,
http://publichealthlawcenter.org/sites/default/files/resources/tclc-guide-restricttobadvert-2011.pdf (last
updated May 2011).
313. See Arlen W. Langvardt, Tobacco Advertising and the First Amendment: Striking the Right
Balance, 5 WM. & MARY BUS. L. REV. 331, 335 (2014), http://scholarship.law.wm.edu/wmblr/vol5/iss2/2
(discussing circuit split resulting from tobacco company challenges to tobacco advertising and promotion
regulations).
314. INSTITUTE OF MEDICINE, PUBLIC HEALTH IMPLICATIONS OF RAISING THE MINIMUM AGE OF
LEGAL ACCESS TO TOBACCO PRODUCTS (Richard J. Bonnie et al. eds., 2015); Bridget Ambrose et al.,
Flavored Tobacco Product Use Among US Youth Aged 12–17 Years, 2013-2014, 314 J. AM. MED. ASS’N
1871, 1872 (2015) (finding that flavors make tobacco products attractive to youth users and about 80% of
youth users of tobacco consumed flavored products); Marianne Wildey et al., Self-Service Sale of
Tobacco: How it Contributes to Youth Access, 4 TOBACCO CONTROL 355 (1995).
315. Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, as
Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and
Distribution of Tobacco Products and Required Warning Statements for Tobacco Products, 81 Fed. Reg.
90 (proposed May 10, 2016) (to be codified at 21 C.F.R. pts. 1100, 1140, 1143); 21 U.S.C. §387(p)
(allowing states to regulate tobacco access more stringently than federal law permits).
316. ALA. CODE §§ 28-11-2, 28-11-3; ALASKA STAT. § 11.76.100 (2016); N.J. STAT. ANN. § 2A:17051.4 (West 2010); UTAH CODE ANN. § 76-10-104 (2010); Adam Nagourney, California Raising Smoking
Age
to
21,
N.Y.
TIMES,
May
4,
2016,
at
A14,
available
at
http://www.nytimes.com/2016/05/05/us/california-raising-smoking-age-to-21.html.
317. See
Tobacco
21
Cities,
TOBACCO
21,
http://tobacco21.org/wpcontent/uploads/2014/02/Tobacco-21-Cities-new-5.pdf (last visited Feb. 19, 2017) (listing all
municipalities that have increased the purchase age for tobacco products to 21).
318. Kristy Marynak et al., State Laws Prohibiting Sales to Minors and Indoor Use of Electronic
Nicotine Delivery Systems – United States, November 2014, 63 MORBIDITY & MORTALITY WKLY. REP.
1145 (2014), https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6349a1.htm (explaining that as of
November 2014, 40 states have prohibited the sale of ENDS to minors).
319. Shari Kessel Schneider et al., Community Reductions in Youth Smoking After Raising the
Minimum Tobacco Sales Age to 21, 25 TOBACCO CONTROL 355, 355–58 (2016).
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The Tobacco Control Act bans the sale of flavored cigarettes and the use of
self-service displays for cigarettes and smokeless tobacco (e.g., customer may
directly handle the product).320 Despite their effectiveness in reducing youth
smoking rates, the Deeming Rule did not extend these provisions to ENDS.321
As mentioned earlier, FDA originally included a flavor ban in its draft final rule,
but the White House Office of Management and Budget removed this
provision.322 Flavored ENDS products are extremely popular among youth and
likely play a role in ENDS initiation.323 More than 85 % of youth ENDS users
prefer flavored products and more than 80 % use ENDS because “they come in
flavors I like.”324 A handful of municipalities, including Chicago, Illinois,
Minneapolis, Minnesota, New York, New York, and Providence, Rhode Island
have enacted sales restrictions on flavored tobacco products.325 The tobacco
industry challenged the Chicago, New York, and Providence ordinances, arguing
that the flavor restrictions were preempted by the Tobacco Control Act and
unconstitutional.326 Each was held to be a legal and valid use of local authority.327
320. Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123 Stat. 1776
(codified as amended in scattered sections of 15 U.S.C. and 21 U.S.C.); 21 C.F.R. §§ 1140.14(c),
1140.16(c) (2014) (banning the sale of tobacco products which do not require a face-to-face interaction,
such as in a vending machine).
321. Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, as
Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and
Distribution of Tobacco Products and Required Warning Statements for Tobacco Products, 81 Fed. Reg.
28974, 29041 (May 10, 2016) (to be codified at 21 C.F.R. pts. 1100, 1140, 1143) (the FDA noting in
response to Comment 166 that restrictions on self-service displays will not apply to newly-deemed ENDS
products).
322. Deeming Final Rule as Cleared by OMB, REGULATIONS.GOV, FDA-2014-N-0189-83195 (posted
May 27, 2016), available at https://www.regulations.gov/docket?D=FDA-2014-N-0189 (deleting all
language enforcing a flavor ban).
323. Ambrose et al., supra note 314, at 1871–72 (finding that the majority of youth who have tried
tobacco report that their first product was flavored and that flavoring is a reason for use across product
types).
324. Ambrose et al., supra note 314 at 1872.
325. CHI., ILL., MUN. CODE ch. 4-64-098, 4-64-180 (2013) (banning the sale of flavored tobacco
products within 500 feet from a school); MINN., MINN., CODE §13-281.45 (2016) (prohibiting the sale of
flavored tobacco products); N.Y.C., NEW YORK, Rules of N.Y.C. §17-715 (2016) (prohibiting the sale of
flavored tobacco products); PROVIDENCE, R.I. CODE ch. 14-308, 14-309 (2012) (prohibiting the sale of
flavored tobacco except menthol, mint, or wintergreen products).
326. See 76 Enterprises, Inc. v. City of Chicago, No. 14-CV-08306 (N.D. Ill. Nov. 4, 2014) (order
denying tobacco company’s request for a temporary restraining order against Chicago flavored-tobacco
ordinance); U.S. Smokeless Tobacco Mfg. Co. v. City of N.Y., 703 F. Supp. 2d 239 (S.D.N.Y. Mar. 23,
2010) (denying injunction sought by tobacco company against ordinance banning sale of flavored tobacco
products); Nat’l Ass’n of Tobacco Outlets, Inc. v. City of Providence, 731 F. 3d 71 (1st Cir. Sept. 30, 2013)
(affirming district court’s judgment in favor of the city against tobacco manufacturer’s challenge to
flavored-tobacco ban).
327. See e.g., Chicago - 76 Enterprises Inc., 1:14-cv-08306 at 4 (noting that many jurisdiction’s
tobacco control ordinances were considered constitutional and within the valid use of local authority); see
also U.S. Smokeless Tobacco Mfg. Co., LLC, 703 F.Supp.2d. at 1(noting that many jurisdiction’s tobacco
control ordinances were considered constitutional and within the valid use of local authority); see also
National Ass’n of Tobacco Outlets, Inc., 731 F.3d at 89 (noting that many jurisdiction’s tobacco control
ordinances were considered constitutional and within the valid use of local authority).

2017] ELECTRONIC NICOTINE DELIVERY SYSTEMS AND THE “DEEMING RULE”

69

Although the tobacco industry may always push the preemption argument, the
statutory language and case law should give confidence to communities
considering flavor restrictions. Other hurdles may exist, such as the process of
enforcing flavored restrictions, so policymakers should be clear and
comprehensive when having such legislation drafted.328
D. Indoor Air Restrictions
Laws restricting indoor smoking are effective at reducing exposure to
secondhand smoke and cigarette smoking rates, particularly among youth.329 As
of October 1, 2016, 25 states and the District of Columbia have enacted
comprehensive laws restricting smoking in indoor workplaces, including bars
and restaurants.330 In addition, tens of thousands of counties and municipalities
have implemented clean indoor air laws.331 These policies vary by location, but
can also include schools, hospitals, college campuses, and other public places.332
Most clean indoor air laws restrict the use of a lighted tobacco product in
the indoor space; since ENDS do not burn tobacco most clean indoor air laws
and policies do not restrict their use.333 While the long-term effects of
secondhand exposure remain uncertain, several public policy arguments support
expanding clean indoor air laws to include ENDS. First, permitting ENDS use
may make it more difficult to enforce existing clean indoor air laws.334 Many
ENDS brands resemble cigarettes and the devices were specifically designed to
mimic the act of smoking.335 Second, the precautionary principle dictates that in
328. See, e.g., Regulation Flavored Tobacco Product, PUB. HEALTH L. CTR. 1, 4 (Sept. 2017)
http://www.publichealthlawcenter.org/sites/default/files/resources/Regulating-Flavored-TobaccoProducts-2017.pdf, (describing the elements of well-crafted laws that communities can easily enforce
them).
329. See, e.g., U.S. DEP’T OF HEALTH AND HUMAN SERVICES, supra note 292, at 795 (noting how
statutes that restricted indoor smoking led to a reeducation in smoking rates, secondhand smoking
exposure, and smoking use in youth populations).
330. See e.g., U.S. 100% Smokefree Laws in Non-Hospitality Workplaces AND Restaurants AND
Bars, AMERICANS FOR NON-SMOKERS’ RIGHTS, http://www.no-smoke.org/pdf/WRBLawsMap.pdf (map
and list downloadable as pdf).
331. Id.
332. Id. (noting that each municipality has unique laws prohibiting indoor use of ENDS with some
banning all indoor use while other municipalities ban them in select locations like schools, college
campuses, and hospitals).
333. See, e.g., Dustin Heap, No Smoking Laws For All Fifty States, SIGNS.COM (May 20, 2014),
https://www.signs.com/blog/no-smoking-laws-for-all-fifty-states/ (noting how most state statues only
cover traditional tobacco products).
334. See, e.g., Kristy Marynak et al., State Laws Prohibiting Sales to Minors and Indoor Use of
Electronic Nicotine Delivery Systems – United States, November 2014, 63 MORBIDITY & MORTALITY
WKLY. REP. 1145 (Dec. 12, 2014), https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6349a1.htm
(explaining how ENDS use could raise hardships in enforcement of smoke-free policies).
335. Chen et al., supra note 4 at 356 (describing closed system e-cigarettes as designed to look like
regular cigarettes); see also E-cigarettes: What are Electronic Cigarettes?, QUIT.ORG,
http://www.quit.org.au/resource-centre/policy-advocacy/policy/e-cigarettes1 (last visited Mar. 10, 2017)
(stating that ENDS are designed to simulate the act of smoking).
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cases of serious threats to health (or the environment) scientific uncertainty
should not be used to delay preventative measures.336 The devastating toll
tobacco has taken on the United States and the globe is undisputed – more than
100 million people were killed by tobacco during the 20th century.337 Until
researchers can determine whether and to what extent ENDS aerosol is harmful,
the use of these devices should be restricted in indoor areas open to the public.
Third, youth are particularly susceptible to tobacco marketing and studies
indicate they perceive ENDS as less harmful (or in some cases safe) compared
to cigarettes.338 Permitting indoor ENDS use could reinforce these beliefs and
promote
youth
ENDS
use.
State and localities have begun to incorporate ENDS into existing clean
indoor air laws.339 At least 10 states have prohibited ENDS use in indoor
workplaces, including bars and restaurants, and more than a dozen others have
restricted ENDS use in schools, government facilities, public transportation and
similar public venues.340 In addition, more than 500 hundred counties and
municipalities across the country have laws regulating the indoor use of
ENDS.341 None of these acts has been the subject of reported legal challenge;
policymakers should be mindful when drafting such a provision to be clear about
the basis for the inclusion of ENDS, relying on the current state of the research
and noting the precautionary principle.342

336. WHO, THE PRECAUTIONARY PRINCIPLE: PROTECTING PUBLIC HEALTH, THE ENVIRONMENT AND
7 (Marco Martuzzi & Joel A. Tickner eds., 2004), available at
http://www.euro.who.int/__data/assets/pdf_file/0003/91173/E83079.pdf.
337. See, e.g., Global Cancer Prevention and Early Detection, AM. CANCER SOC’Y,
http://www.cancer.org/aboutus/globalhealth/tobacco-control (last visiting Mar. 10, 2017) (explaining how
100 million people were killed by tobacco in the 20th century and as many as 1 billion are expected to die
in the 21st century).
338. See U.S. DEP’T HEALTH & HUMAN SERVICES, PREVENTING TOBACCO USE AMONG YOUTH AND
YOUNG ADULTS: REPORT OF THE SURGEON GENERAL 512 (2012) (noting studies that have found that
advertisements often increase adolescents’ desire to smoke); see B.K. Ambrose et al., Perceptions of the
Relative Harm of Cigarettes and E-Cigarettes Among U.S. Youth, 47 AM. J. PREVENTIVE MED., S53-S60,
1, 7 (2014) (indicating that adolescents who perceive a continuum of cigarette related harm consistently
perceived e-cigarettes as less harmful than conventional cigarettes).
339. States and Municipalities with Laws Regulating Use of Electronic Cigarettes, AM.
NONSMOKERS’ RIGHTS FOUND. (Jan. 2, 2017), http://www.no-smoke.org/pdf/ecigslaws.pdf.
340. Id. at 1–2.
341. Id. at 4–19.
342. The Federal Aviation Administration has banned the use of ENDS on airplanes. Use of
Electronic, 81 Fed. Reg. 11,415 (Mar. 4, 2016) (codified at 14 C.F.R. pt. 252), available at
https://www.gpo.gov/fdsys/pkg/FR-2016-03-04/pdf/2016-04799.pdf. That ban has been challenged by
ENDS manufacturers. Brief for Petitioners, Competitive Enterprise Institute v. U.S. Dep’t of Transp., No.
16-1135 (Nov. 22, 2016), available at http://casaa.org/wp-content/uploads/2016-11-22-cei-final-replybrief.pdf. The outcome of that case will likely inform policymakers moving forward with adding ENDS
to clean indoor air laws. Id.
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E. Taxation and Minimum Price Strategies
Increases in the purchase price of tobacco products can significantly reduce
the prevalence of youth use. Studies estimate that a 10 % increase in price will
result in a 5-15 % reduction in overall youth consumption.343 The two primary
methods of increasing tobacco prices are taxation and minimum price laws.344
The Federal government, all 50 states and the District of Columbia, and hundreds
of municipalities impose excise taxes on the sale of cigarettes and other tobacco
products.345 Since 2002, 47 states and the District of Columbia have raised their
cigarette excise tax rates a total of 126 times.346 Over this same time period
reported smoking rates among U.S. high school students decreased from 22.2 to
9.3 %.347 Minimum price laws typically establish a minimum wholesale or retail
price under which products may not be sold.348 Originally intended to prevent
predatory price cutting, states and localities have begun to recognize the public
health benefit of minimum price laws. In 2013, New York City passed the
highest minimum price law in the country, setting the minimum legal price for a
pack
of
cigarettes
at
$10.50.349
Communities have begun applying similar pricing policies to ENDS in an
effort to reduce youth use.350 Jurisdictions may include ENDS in their definition
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http://www.cdc.gov/tobacco/data_statistics/fact_sheets/youth_data/tobacco_use/ (last updated Apr. 14,
2016) (stating that 9.3 % of high school students reported in 2015 that they smoked cigarettes in the past
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of cigarettes or other tobacco products, which then subjects these products to the
existing product tax, or separately define ENDS in the tax code.351 Alternatively,
ENDS may be taxed based on the volume of e-liquid or the amount of nicotine.352
Under this method accurately calculating the tax may prove difficult since eliquid is sold in a wide-range of sizes and nicotine concentrations. For this
reason, an ad valorem tax (e.g., based on the price of the product) is preferred,
regardless of whether ENDS are incorporated into the existing definition of
tobacco products or separately defined in the tax code.
IX. CONCLUSION
Because the road to federal regulation of tobacco products was long and
arduous—and remains so—federal regulation of ENDS, just about a decade after
the product entered the market, seems swift.353 Yet the FDA deeming rule is a
tiny step in the scheme of regulating this ever-changing product that clearly poses
some harm to individual and population health yet may hold some promise for
smoking cessation. More comprehensive, sound research is needed for
policymakers and public health officials to make the best policy decisions
regarding the marketing, sale and use of ENDS. As that research progresses and
FDA begins to implement the basic provisions applicable to ENDS via the
deeming rule, state and local governments are considering policy options to
prevent ENDS use from increasing, particularly among youth and those who
have never smoked cigarettes. Using the framework of effective tobacco
regulation and the preliminary research supporting a need for action,
policymakers should consider what restrictions make sense for their
communities.

Landscape-50-State-Review-September-2016.pdf (last visited Mar. 10, 2017) (stating that Minnesota
imposes a ninety-five % tax on the wholesale price of e-cigarettes).
351. See LEGAL RESOURCE CTR. FOR PUB. HEALTH POL’Y, supra note 350 (stating that e-cigarettes
and e-juice are considered tobacco products in Minnesota and are subject to the Tobacco Tax, which is
currently ninety-five % of the wholesale cost of any product containing or derived from tobacco).
352. See, e.g., KAN. STAT. ANN. § 79-3399(a) (2015) (“On and after January 1, 2017, a tax is hereby
imposed upon the privilege of selling or dealing in electronic cigarettes in this state by any person engaged
in business as a distributor thereof, at the rate of $.20 per milliliter of consumable material for electronic
cigarettes and a proportionate tax at the like rate on all fractional parts thereof.”); LA. REV. STAT. ANN §
47:841F (2017) (“Upon vapor products and electronic cigarettes, a tax of five cents per milliliter of
consumable nicotine liquid solution or other material containing nicotine that is depleted as a vapor
product is used.”); N.C. GEN. STAT. ANN. § 105-113.35(a1) (2016) (“An excise tax is levied on vapor
products at the rate of five cents (5¢) per fluid milliliter of consumable product.”).
353. See supra Section VI (describing the decade-long legislative battle that ensued before the
President signed into law the Family Smoking Prevention and Tobacco Control Act).
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